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CHAPTER 1 
GENERAL INTRODUCTION AND OUTLINE OF THE STUDY 
A. GENERAL INTRODUCriON 
Introduction 
Osteogenesis imperfecta (ΟΙ) is a heterogeneous group of inherited conditions arising 
from a variety of biochemical and morphological collagen defects. Apart from the 
brittleness of the bones and the susceptibility of affected individuals to bone fractures 
from very mild trauma, other manifestations of abnormalities in bones, teeth, sclerae, 
ligaments and other collagen containing tissues indicate the heterogeneity of the 
condition. Although the "brittle bone" aspect of OI is its hallmark feature, OI is a 
generalized disorder of connective tissue. Affected individuals may have non-osseous 
features such as blue sclerae, hearing loss, dentinogenesis imperfecta1, growth 
deficiency, loose or dislocated joints, cardiopulmonary abnormalities,2,3 easy bruising, 
hypermetabolic states with excessive sweating and metabolic acidosis,4,5 basilar 
impression and other neurological complications.6,7 
The incidence of OI is estimated to be 1 in 20,000-30,000 newborns;8"13 whereas Byers 
stated that OI phenotypes occur in about 1 in 5000 to 1 in 10,000 subjects.14 The 
prevalence corresponds with the smaller incidence.15 It is estimated that there are 
approximately 600 OI sufferers in the Netherlands, most of whom have OI type I. 
Until recently, patients were classified as having a congenital form or a tardive form 
of OI. In the "congenita" and "tarda" classification, congenita cases were generally 
severe, because, by definition, the diagnosis could be made at birth. This group 
included cases with the lethal form as well as the cases more likely to survive. There 
was no accounting for genetic patterns. Tarda cases were those recognized beyond the 
neonatal period. These cases were generally milder than congenita cases and could 
anticipate further improvement subsequent to puberty. Emphasis on the time of 
diagnosis failed to account for cases noted at birth in families with a relatively mild 
form of the disease and the considerable variation in the prognosis of congenita cases. 
The classification now in general use among geneticists was first proposed by Sillence 
et al.8 in 1979 and has been extended since then by him and others.1,16"19 The clinical, 
radiographic and genetic classification divides OI into four types (Table 1). Although 
some cases and/or families do not fit into any of the Sillence OI types as precisely 
defined,20 the broad groups have provided a common groundwork for discussion and 
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Table 1: Classification of Osteogenesis Imperfecta Syndromes 1 
Ol type' Description of clinical features Biochemical and genetic abnormalities 
I AD Normal, sometimes mild short stature 
Mild-to moderate bone fragility with 
hltlc or no deformity 
Blue sclerae 
Hearing loss in almost 50% 
Dentinogenesis imperfecta (Dl) is rare 
OI type IA DI is absent 
OI type IB DI is present 
Easy bruising 
Common 'Non-functional' COL1A1 allele 
Rare Substitution for glycine residue in 
carboxyl terminal tclopeplide of a 1(1) 
Substitution of glycine at position 94 of the 
the triple helix in pro α 1(1) 




Lethal in the perinatal period 
Extreme fragility connective tissue, 
multiple fractures in utero, 
usually intcrutcnnc growth retardation 
Minimal calvaría! mineralisation, 
soft large cranium 
Micromeha, long bones crumped and 
bowed, ribs beaded, platyspondyly 
Common Substitutions for glycyl residues in 
the triple helical domain of the α 1(1) and 
a-2(I) chain 
Rare Rearrangements in COL1A1/COL1A2 
Exon deletions in the triple helical domain 
Substitutions and small deletions in the non-
triple helical carboxyl-terminal propeptide 
Tnpeptide deletion in pro-a-l(I) triple helix 
Small deletion in a-2(I) on ihe background 
of null allele 
m AD Progressively deforming bones, 
usually with moderale deformity 
at birth, caused by severe fragility 
of bones and fractures in ulero 
Stature very short, kyphoscoliosis, 
severe osteoporosis 
Sclerae variable in colour, 
often lighten with age 
Dentinogenesis imperfecta common 
Hearing loss common 
AR 
IV AD Normal sclerae (slightly blue 
or greyish in infancy) 
Mild to moderate bone deformity, 
often bowing of long bones, 
scoliosis and variable short stature 
Skeletal fragility and osteoporosis 
more severe than type I 
Dentinogenesis imperfecta (DI) 
Ol type IVB (mostly) DI is present 
OI type IVA DI is absent 
Hearing loss occurs in some 
Point mutations in COL1A1 and COL1A2 
gene 
Framcshift in COL1A2 that prevents ihe 
incorporation of pro-a-2(I) chains 
Point mutations in COL1A1 and COL1A2 
gene 
* AD, autosomal dominant, AR, autosomal recessive 
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research. In 1987 during the Third International Conference on Osteogenesis 
Imperfecta in Pavia, Italy, consensus was achieved to retain the Sillence classification 
while research continued, to add a more molecular emphasis to the nomenclature.21 
History 
Historical investigation is complicated by the fact that OI has been discussed under 
numerous eponyms (Table 2).22 
The discovery in 1967 of OI in an Egyptian infant dating from the 21st Dynasty (about 
1000 B.C.) represents the earliest known case of the disease (Figure I).23 
According to Seedorff, the first case suggestive of OI was that of a mythical Danish 
prince, Ivar Benl0s (boneless), son of Aslaug and King Ragnar Lodbrog, who lived in 
the ninth century and who had to be carried into battle on a shield as he was unable 
to walk on his soft legs.24 Unlike the Egyptian Mummy, further studies on his bones 
were allegedly prevented by William the Conqueror who, after his conquest, opened 
Ivar's grave and burnt the body. 
Table 2: Numerous eponyms under which osteogenesis imperfecta has been 
discussed22 
Adair-Dighton disease (syndrome) 
Aplasia periostalis 
Blegvad Haxthauscn syndrome102 
Blue sclera syndrome 
Blue sclerotics and brittle bones 
Blue scleras and fragilitas ossium 
Brittle bones and blue sclerae 
Dark sclerotics and fragilitas ossium 
Dysplasie periostale 
Dystrophie periostale 





Fragilitas vitrea ossium 
Fragilité osseuse congénitale 
Hereditary fibrous osteodysplasia 
Hereditary hypoplasia of the mesenchyme 
Lobstein's disease 
Malacia mycloplastica 
Maladie de Porak-Durante 
Maladie de Lobstein 
Micromelia annularis chondromalacia 
Molities ossium 
Osseous fragility 
Osteogenesis imperfecta congenita (Vrolik) 




Osteopsathyrosis idiopathica (Lobstein) 
Osteopsathyrosis foetalis 
Osteitis parenehymatosa chronica 
Rachitis congenita 
Spurway - Eddowes syndrome 
Van der Hoeve - De Kleyn syndrome 
Vrolik disease (syndrome) 
12 
Figure 1: Infant in cartonnage case from the 21st Dynasty (c. 1000 B.C.) in the 
form of an Osiris figure. The height is 73 cm and it is remarkable that 
the case is surmounted by double plumes. It resembles closely a normal 
figure of Ptah-Seker-Osiris. 
The case was found by Professor John Garstang in 1905 at a site known 
as the Speos Artemidos in the necropolis of Beni Hasan, the site of an 
ancient Egyptian town on the East Bank of the Nile. 
The perculiar bowed appearance of the removed and unwrapped bones 
and the triangular shaped skull suggested to the excavators that the 
remains were those of a mummified monkey. 
Copynghts reserved by The British Museum, Department of Egyptian Antiquities, London. 
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Malebranche wrote the first known case report in 1674. He described a 20-year-old 
mentally retarded male whose bones resembled those of a condemned criminal 
broken on the wheel. During the next century, other authors described patients 
suffering from congenital fractures attributed to the fact that their mothers had 
witnessed the execution of a criminal upon the wheel while the child was in utero.24 
The first scientific description of the disease was given by Olaus Jakob Ekman, chief 
surgeon in the Swedish army, who held his medical degree thesis on May 10, 1788 by 
describing a family afflicted by "congenital osteomalacia" in three generations.26 This 
work was resurrected and published by Seedorff in 1949.24 
That OI affects other organs as well as bones was first noted in 1831 by Edmund 
Axmann, who suffered from the disease himself as well as two of his brothers and 
who gave the first clear account of four major characteristics of osteogenesis 
imperfecta: bone fragility, hypermobile joints permitting easy dislocation, blue sclerae 
and frail body build.27 His contribution to medical knowledge was overlooked until 
1958 when Caniggia et al. credited him with being the first to recognize some of the 
complex aspects of what had first been thought to be merely "brittle bone disease".28 
He also advanced the hypothesis that these defects could be caused by a weakness in 
fibrous tissues. Lobstein received medical acclaim as the first to recognize the 
hereditary nature of fragile bones when he described "osteopsathyrosis idiopathica" in 
1833, because the work of Ekman (1788)26 had remained unnoticed for a long time.29 
The entity Lobstein described probably corresponds with what is now referred to as 
one of the dominant OI types, according to the Sillence classification.8 Weil (1981) is 
not certain whether Lobstein described osteoporosis or osteopsathyrosis.22 Uptill now, 
this condition of OI was often seen in the French literature as "la maladie de 
Lobstein". 
In 1849, Vrolik introduced the term "osteogenesis imperfecta" by describing an infant 
with imperfect osteogenesis, multiple congenital fractures, a large head with probably 
Wormian bones and who succumbed on the third day of life.30 This is the first treatise 
on what in earlier days we would have called OI congenita and nowadays would 
classify as a mild form of OI type II or a severe form of OI type HI, according to 
Sillence.8 
For several decades, osteogenesis imperfecta congenita (Vrolik) and osteopsathyrosis 
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idiopathica (Lobstein) were thought to be two different diseases both related to 
rickets. Schmidt (1859) concluded from an autopsy that the condition would be best 
described as chronic parenchymatous osteitis, differing from osteomalacia, rachitis or 
ordinary osteitis.31 This may be the first histological description of OI. Stilling (1889) 
disproved the relationship between rickets and OI on histological grounds.32 In 1898, 
Kaufmann recognized that OI, achondroplasia and rickets were different entities.33 
Histological examinations by Looser (1906) provided conclusive evidence that the 
microscopic picture of OI and osteopsathyrosis was similar.34 Looser also made a 
distinction between OI congenita and OI tarda. 
Unaware of Axmann's earlier report (1831), Spurway (1896) and Eddowes (1900) 
once again observed that blue sclerae was a finding associated with the hereditary 
tendency to fracture.35,36 
Preiswerk (1912) observed that the incisors of a four-year-old girl afflicted with 
osteogenesis imperfecta were fairly small and had a brownish-grey color shining 
through them.37 He emphasized that this was what he called tooth rickets or tooth 
involvement with osteogenesis imperfecta independent of osteogenesis imperfecta of 
the bone of the mandible. Bamberg and Huldschinsky (1913), searching for a 
biochemical explanation, failed to find abnormalities in serum calcium and 
phosphorus.38 Ostheimer (1914) described a young affected child with a warm, moist 
skin.39 In 1918 Voorhoeve emphasized the possibility that osteogenesis imperfecta was 
due to a genetic disorder of the mesenchyme.40 He stated that the presence of 
labyrinthine involvement strengthened his theory of mesenchymal inferiority. Bauer 
(1920) may have been the first to describe symptoms of a haemorrhagic tendency 
when he noted that OI patients were highly susceptible to bruising.41 He attributed 
the abnormalities to "mesenchymal inferiority" and thorough investigations of dental 
tissues, cartilage, skin and blood vessels, summarized in 1940, made him the foremost 
proponent of a generalized mesenchymal disorder as the cause of OI.42 
The first author who added hearing impairment to fractures and blue sclerae was 
Adair-Dighton (1912), ignorant of the fact that this was the first description of the 
triad of OI.43 His reference to "nerve deafness which started three months after birth 
of child" in a woman seen 18 months later seems quite casual. It is probably more 
accurate to credit Dent with this finding, because in 1897 he described a case of 
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fragilitas ossium and deafness in the absence of blue sclerae.44 However, by studying 
the picture of the patient and the skiagraphs of his deformed and bowed bones, it 
could have been a case of OI type IV, which is known to be associated with sclerae of 
grayish blue or even white. 
Van der Hoeve and De Kleyn, who eponymed the syndrome, presented a paper to a 
clinical meeting in Utrecht in 1916 in which they claimed that the deafness in this 
triad was conductive in type and clinically indistinguishable from otosclerosis. The 
hearing loss in one family occurred in each of the four generations except the 
youngest one and in 11 out of 22 family members. However, their paper was not 
published until 1917 in Dutch and until 1918 in German.45,46 The X-ray studies of 
their patients were done by Stenvers who described a calcareous deposit of sclerosis 
of the petrous bone.47 This is the first reported use of X-rays of the petrous pyramid 
to diagnose involvement by osteogenesis imperfecta. He was also the first to notice an 
abnormal blueness of the drums. By that time, Bronson (1917) had independently 
described 19 cases with hearing loss associated with bony fragility in one family and 
wrote the most comprehensive review of the subject to that date.48 It would appear 
that she was the first to describe the symptom of dizziness in OI patients whose 
hearing was impaired. Bronson adduced the theory that the deposition of calcium salts 
in the middle ear might be responsible for the hearing loss. The otological 
examination of her patients was performed by Fraser (1919) who found "flamingo 
pink" colour over the promontory in some patients, corresponding with what is 
nowadays known as Schwartze's sign.49 In addition, he found hearing loss of the 
conductive type and in one patient vertigo. It was Eraser's clinical opinion that the 
deafness in OI was due to otosclerosis. Ruttin (1922) reported otosclerotic placques at 
the anterior border of the oval window of patients who had blue sclerae and a history 
of multiple fractures.50 Weber (1930) noted some similarity between the callus of a 
healing fracture in osteogenesis imperfecta weblike pathologic fiber bone and that of 
the so-called blue bone in otosclerosis.51 He assumed that in addition to the similar 
mode of the hereditary transmission of the two diseases and the frequent association 
of otosclerosis with osteogenesis imperfecta and blue sclerae, the histogenic 
relationship between the two diseases pointed to a common genesis.52 Weber's ideas 
have started a chain reaction of misunderstandings for several decades. Until the 
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1970s, the changes in the middle ear in osteogenesis imperfecta were considered to be 
a severe form of otosclerosis because otosclerotic changes were found in histologic 
examinations of temporal bones.53 55 In otosclerosis four stages m the development of 
the otosclerotic lesion are usually seen: the first stage is the formation of an active 
otospongiotic lesion with large resorption spaces containing cellular fibrous tissue; 
subsequently an immature basophilic bone is formed; in the third phase remodelling 
with resorption and new bone formation takes place, resulting in a more mature 
acidophilic bone with a laminated matrix; finally, an inactive highly mineralized 
otosclerotic bone with a mosaic-like appearance is formed.56,57 Indeed in some rare 
cases of osteogenesis imperfecta the histopathologic changes in the footplate 
resembles the early otospongiotic lesion of otosclerosis like Weber (1930) believed 
was right.51 
For many years this problem remained unsolved whether the changes in OI should 
belong to the disease itself or could be determined as a severe form of otosclerosis.53 
55,58-63 -p^g p r e s e n c e 0f early otospongiiic lesions advcates the otosclerosis theory, 
however the fact that it only occurs in rare congenital forms of OI pleads strongly 
against it. In favour of the OI theory was revealed that a greater degree of structural 
disorganization and larger resorption spaces of the stapedial lesion in OI distinguished 
the two conditions.64"66 There is also a difference between the appearance of the 
stapes suprastructures in OI and otosclerosis, e.g. ossicular discontinuity and even 
fractures of the crura. Only in a few cases proper histologic examination of the crura 
demonstrate that some areas were replaced by fibrous connective tissue, most likely 
due to previous fractures.61,67'70 
The last decade has shown that there is a clear distinction between some histological 
features in OI and those in otosclerosis.70 72 Firstly, there is deficient ossification of the 
three layers of the otic capsule, the bony walls, and ossicles of the middle ear in OI. 
Secondly, there is evidence of abnormal ossification. Thirdly, in OI microfractures of 
the otic capsule and the middle ear ossicles occur. 
Biochemical and genetic aspects 
Biochemical studies on bone and skin collagen from OI patients have shown that the 
basic defect involves structures of collagen itself.73 In recent years, important 
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discoveries have helped to elucidate the identity of new collagen types, the structure 
of procollagens and the processes involved in collagen synthesis and degradation.74"78 
In several different types of collagen molecule, quantitative and qualitative changes in 
type I collagen synthesis causes OI. For type I collagen molecule synthesis, which 
forms a substantial part of bone matrix, skin, blood vessels and other fibrous tissues, it 
is necessary to have two a-l(I) and one a-2(I) chains for producing a molecule 
heterotrimere. Molecule synthesis can be disturbed by several gene mutations that 
cause a specific OI phenotype. Two genes, COL1A1 located on chromosome 17 and 
COL2A1 located on chromosome 7, encode the pro-a-l(I) and pro-a-2(I) chains of 
type I procollagen, respectively.79,80 These genes each contain more than 50 exons that 
contain the coding sequence for proteins of about 1400 amino acids. 
The genes are coordinately transcribed, the mRNAs are processed and transported to 
the cytoplasm where they are translated on membrane bound polysomes (Figure 2). 
The precursor proteins are inserted through the membrane of the rough endoplasmic 
reticulum and the signal sequences are cleaved. Each procollagen molecule contains 
two pro-a-l(I) chains and a single pro-a-2(I) chain. The correct assembly of molecules 
is directed by interaction of the pro-a-chains through their carboxyl-terminal globular 
domains. After aggregation in the 2:1 ratio, the chains fold the triple helix from the 
carboxyl-terminal end towards the amino-tcrminus. The completed molecule is 
transported out of the cell through the Golgi apparatus and deposited in the 
pericellular environment where the two propeptides are cleaved from the molecule 
and the collagen molecules spontaneously aggregate to form fibril structures. The 
formation of fibrils depends on the uniformity of subunits and abnormal molecules 
have highly deleterious effects on fibril structure. 
The identification and characterization of mutations in collagen genes has provided 
unexpected insight into structural requirements for specific domains, the role of these 
domains in molecular assembly and secretion and, to a lesser extent, the way in which 
mutation is translated to disease phenotype. 
The phenotypic manifestations of mutations in collagen genes reflect the tissue 
distribution of the gene products.81 Most mutations in the genes for type I procollagen 
result in all forms of OI and rare forms of the Ehlers-Danlos syndrome (type VII) 
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Figure 2: Diagrammatic representation of the assembly of collagen fibers by a 
fibroblast. Type I collagen, the most common type of collagen, is first 
synthesized as a precursor molecule that is called type I procollagen and 
that consists of two identical pro-a-l(I) chains and one slightly different 
pro-a-2(I) chain. The intracellular assembly of the procollagen molecule 
occurs primarily in the cisternae of the rough endoplasmatic reticulum 
(lower left). After procollagen is secreted from fibroblasts, the amino-
propeptides on each of the three pro-a chains are cleaved by one 
proteinase, and the carboxy-propeptides on the three chains are cleaved 
by a second proteinase (lower right). After the propeptides are cleaved, 
the collagen molecule spontaneously self-assembles into the quarter-
staggered array that gives collagen fibers their characteristic surface 
pattern of cross-striations. 
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characterized by hyperextensible joints. Mutations in the genes that encode the chains 
of type II procollagen result in some of the chondrodysplasias.82 Mutations in the 
COL3A1 gene affecting the type III procollagen structure result in a form of the 
Ehlers-Danlos syndrome (type IV) characterized by vascular and bowel fragility.83 
Furthermore, a mutation in one of the genes of the type IV procollagen (COL4A5) 
may cause the X-linked Alport syndrome.84 
The products of the other collagen genes are less accessible because of the restricted 
range of tissue expression, the relatively low abundance of proteins and the difficulty 
of growing differentiated cells from tissues such as cartilage (types II, IX, X, XI). As a 
result of some of these difficulties, the phenotypic consequences of mutations in most 
collagen genes are still unknown. 
During the 1990 International Conference on Osteogenesis Imperfecta in Pavia, Italy, 
it became clear that more than 80 different mutations of the COLlAl and COL1A2 
genes had been identified in patients with OI to date.85 
Point mutations are the most common events that lead to OI phenotypes. These 
mutations 1) may result in substitutions for glycine residues within the triple helix, 2) 
may produce exon skipping events if they occur in the consensus splice donor or 
acceptor sites, or 3) may alter the ability of chains to aggregate into molecules if they 
occur within the domains that encode the carboxyl-terminal propeptide. 
In OI type I, it has been shown that only half of the normal quantity of pro-a-l(I) 
collagen is produced, which is mainly caused by mutations in one allele of the 
COLlAl gen.86 
For OI type II, the most fully researched form of OI, it is known that various 
mutations can occur in the COLlAl gen and in the COL1A2 gen. These mostly 
comprise point mutations in the COLlAl gen, which can lead to the substitution of 
glycine for cystine in the triple-helix part of the a-l(I) chain. In addition, 
rearrangements can occur in the COLlAl gen and the COL1A2 gen and a small 
deletion in het COL1A2 gen. In most cases, these are dominant mutations.87 
Less research has been conducted into OI type Ш. It has been found that a recessive 
form exists, in which a frame-shift mutation occurs in the COL1A2 gen, which 
prevents the incorporation of pro-a-2(I) collagen into the type I collagen molecule so 
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that they only contain pro-cr-l(I) chains.88,89 A dominant form of OI type III is also 
possible, involving point mutations in the COL1A1 gen or the COL1A2 gen, which 
can affect the stability of the triple-helix.90 One of the resulting phenotypes, in which, 
for example, cystine is incorporated instead of glycine at a specific site, can be 
biochemically related to the dominant OI type II (point mutation in the COL1A1 gen) 
or the dominant OI type IV (point mutation in the COL1A2 gen). 
For OI type IV, it is reported that in the majority of patients, point mutations in the 
COL1A2 gen produce changes in about half of the pro-a-2(I) collagen chains.91 
Furthermore, in a minority of cases, small deletions occur in the COL1A2 gen or 
point mutations in the COL1A1 gen.92 
The types of mutation in the type I collagen genes which produce the different 
phenotypes of OI have now become clear. Although these findings are of great 
interest, such a broad spectrum of abnormalities points to the heterogeneity of the 
syndrome and to the vast amount of investigation still needed to elucidate the basic 
biochemical alterations that are expressed. Significant questions remain, however, 
about how a given collagen sequence alteration contributes to the molecular 
pathogenesis of OI. The common effects of the different classes of mutations provide 
a first approach to unifying mechanisms. All the mutations in collagen genes that 
produce OI, result in the decreased synthesis and secretion of normal type I 
procollagen.92 When no abnormal type I procollagen is synthesized, the phenotype is 
generally quite mild (OI type I). When abnormal molecules are synthesized, the 
phenotype can range from very mild to lethal, depending on the nature of the 
mutation and its effect on molecular assembly and stability, on the secretion of 
abnormal molecules and, presumably, on the ability of the abnormal molecules to 
disturb normal fibrillogenesis. Abnormal molecules are generally secreted less 
efficiently than normal ones but, once secreted, can become incorporated into a 
matrix where they probably disrupt the fibrils in many tissues. In bone, the fibrils that 
incorporate abnormal molecules may not be mineralized as efficiently as those 
containing only normal molecules. The number of abnormal molecules that it takes to 
produce abnormal fibrils may be surprisingly small because of the constraints on 
molecular dimensions needed to pack molecules into fibrils. 
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Variable expression is characteristic for the dominant OI types. Within one OI family 
with the same basic biochemical defect, a large variation of phenotypes can occur. It 
is likely that additional gene products influence the phenotypic manifestations of 
familiar mutations.93 
It can be concluded that the accumulating data suggest that OI is caused by 
qualitative and quantitative changes in type I collagen synthesis. OI type I has been 
shown in a number of cases to result from the decreased synthesis of structural 
normal collagen. On the other hand, in OI types II and IV, the synthesis of a 
structurally abnormal collagen occurs in normal amounts, but because of the 
decreased stability, the total collagen production is reduced. Our knowledge of what is 
wrong with the collagen molecules produced in OI, is steadily and rapidly increasing, 
whereas the question of why things subsequently go wrong is far less well understood. 
This discrepancy is especially evident in families displaying variable phenotypic 
expression, which is probably due to the modulating effect of connective tissue 
components other than collagen. 
Over the next few years it will be important to clarify genotype-phenotype 
relationships, to determine how defective molecules function, to determine more of 
the natural history of different forms of OI, to identify and characterize the genes 
which modify the effects of the primary mutations and to translate research studies on 
the molecular basis of OI into information for families and physicians.94 
In the future new biochemical knowledge on bone and skin collagen from OI patients 
makes further subdivision on the basis of biochemical characteristics plausible. 
B. PURPOSE OF THIS STUDY 
The aim of this study was to gain more insight into the nature and the variation in 
severity of the hearing loss in patients with OI, also in relation to age. Such knowledge 
is of great significance for career opportunities for people affected by this condition. 
Also the hearing loss and the results of stapes surgery are subjects of further study. 
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This is of importance in order to establish the efficacy of stapes replacement surgery 
with regard to improving the individual patient's hearing. 
In 1985, a research project was started, supported by the collaboration between the 
Ear, Nose and Throat Department of the University Hospital Nijmegen and the 
Stichting Bio-Kinderrevalidatie (Foundation for paediatric rehabilitation) in Arnhem. 
The objects of this study were as follows: 
1. What is the penetrance of OI type I and what is the expression of the most 
common features including hearing loss. 
2. What is the nature and degree of hearing loss in sufferers of OI type I and how 
does the hearing loss relate to age. 
3. What are the short and long term results of stapes surgery in osteogenesis 
imperfecta. Is there a relation between surgical findings and results of stapes 
surgery. 
4. Can the results of stapes surgery be predicted with special reference to cases with a 
poor results of surgery. 
С POPULATION AND METHODS 
In the early phase of the study, there appeared to be ample data available at the 
ENT Department in Nijmegen on osteogenesis imperfecta (type I) patients (including 
surgical details) and their families. However, when the data were evaluated in the 
light of the research questions, the population proved to be too small to provide 
adequate answers to the separate questions. Thanks to the kind cooperation of the 
Nederlandse Patiëntenvereniging Osteogenesis Imperfecta (Dutch Society for OI 
Patients), a large population of osteogenesis imperfecta (type I) patients and their 
families could be collected, visited and examined. A considerable number of ENT 
specialists participated in the study by supplying data, which ultimately formed the 
largest group of osteogenesis imperfecta (type I) patients to date who had undergone 
stapes surgery. It should be mentioned that part of the data was retrospective and 
part could be studied prospectively. 
Hearing loss has been described in association with every known type of OI. During 
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the study, it became clear that for the time being, it was only possible to collect 
sufficient data on patients with OI type I. Therefore, the study questions were not 
extended to incorporate other types of OI besides type I. 
In the early phase of the study, the abnormality was referred to as osteogenesis 
imperfecta tarda.95 In the first phase, when the stapes surgery was often studied 
retrospectively (Chapters 4 to б),96"98 the abnormality was described as osteogenesis 
imperfecta without any further specification of the type, according to the classification 
of Sillence. In the next phase in which the clinical genetic aspects (Chapter 2 ) " and 
the relation between the degree of hearing loss and age (Chapter 3)1 0 0 were studied, it 
was necessary to apply the strict description of osteogenesis imperfecta type I. 
For the latter two Chapters, data were required with as little patient selection as 
possible. Family studies were conducted with the aim of collecting reliable data, so 
that any possibly unfavourable selection, which may influence the results, would be 
detected. In this way, we were able to establish in retrospect on clinical genetic and 
anamnestic grounds that nearly all the patients in Chapters 4 to 6 had osteogenesis 
imperfecta type I. 
More details on the definition of the populations and the methods used are given in 
the seperate chapters which have been published a seperate entities. 
In Chapter 2, the penetrance of osteogenesis imperfecta type I and the expression of 
the most common characteristics are assessed in 30 fully-investigated families with at 
least two generations of OI sufferers. Distinction is made between families with and 
without male-to-male inheritance, to exclude an X-dominant pattern of inheritance 
and genetic imprinting. 
In Chapter 3, the nature and the degree of hearing loss in patients with osteogenesis 
imperfecta type I is discussed. In addition, an analysis is made of the influence of age 
on the degree of hearing loss. The progression of the hearing loss is described on the 
basis of the clinical genetic study. 
In Chapter 4, the results of stapes surgery are given for the patients with osteogenesis 
imperfecta (type I) at the ENT Department of the University Hospital Nijmegen. The 
hearing thresholds in the pre-operative period as well as the short-term and long-term 
results are presented together with the surgical findings. 
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In Chapter 5, a review is made of the short-term and long-term results of stapes 
surgery in osteogenesis imperfecta (type I) for the whole of Holland. A detailed 
comparison is made with two other studies on short-term and long-term hearing 
gain.9·101 
Chapter 6 analyses the initially disappointing-looking results of stapes surgery in 
patients with osteogenesis imperfecta (type I). A search is made for characteristics 
which may have predictive value even before surgery. Besides the sex distribution in 
the study population, the number of fractures, the age at the onset of hearing loss and 
the age at which stapes surgery took place, various specific characteristics and surgical 
details are compared to those reported in two other studies and to those reported in a 
collection of smaller studies we selected from the literature. 
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ABSTRACT 
In 30 fully investigated family pedigrees in which there were at least two generations 
of people suffering from osteogenesis imperfecta type I (McKusick no. 16620), the 
data on 144 random offspring could be used for segregation analysis. The major 
characteristics, blue sclerae, fractures and hearing loss were present in every pedigree. 
Their penetrance was also calculated. 
Precise definitions were used in the study. The segregation ratio was 70:72. The 
incidence of blue sclerae was 70:70 (100%), for fractures 61:70 (87%) and for hearing 
loss 30:70 (43%). There was a very clear relationship between age and the 
progression of the hearing loss. 
Dividing the offspring into two groups depending on whether or not male-to-male 
inheritance was present and performing segregation and penetrance calculation on 
these data, did not produce any indications that there are two genetically 
distinguishable subtypes of osteogenesis imperfecta type I. In a smaller group of 107 
offspring, calculations could be made on several separate generations. 
INTRODUCTION 
Over the past ten years, our knowledge on the clinical-genetic aspects of osteogenesis 
imperfecta (OI) has increased rapidly. The new classification system introduced by 
Sillence et al.1 together with the later additions,2"5 the recent discoveries on the 
molecular structure of collagen6 and its biosynthesis,7"10 has helped to solve many of 
the mysteries and improve the quality of genetic counseling. 
In 1987, it was decided to continue using Sillence's vigilant classification, despite the 
fact that several questions had remained unanswered, due to of a lack of knowledge 
on both the biochemical and genetic heterogeneity of the disease.11 
In this study, segregation and penetrance analyses were performed on a random 
group of offspring from families with osteogenesis imperfecta type I. We also 
examined whether a distinction could be made between offspring with and without 
male-to-male inheritance, to demonstrate the possible existence of two different 
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genotypes of osteogenesis imperfecta type I. 
PATIENTS AND METHODS 
For the present study, as much data as possible was collected on patients with 
osteogenesis imperfecta in the Netherlands. The majority of patients were found to 
have osteogenesis imperfects type I on the grounds of their anamnesis and physical 
examination, which showed the presence of the following in the proband and at least 
two generations of relations: blue sclerae, fractures, hearing loss, hyperlaxibility and 
other possible characteristics (McKusick no.16620).12 Classification was not made on 
the basis of dwarfed growth or curvature of the long bones. There were far less 
patients with osteogenesis type III (McKusick no.25942) and type IV (McKusick 
no.16622). None of our patients had ever undergone a diagnostic test, e.g. fibroblast 
culture, to prove the presence of osteogenesis imperfecta. 
In order for the segregation and penetrance analyses to be accurate, it was necessary 
to prevent several possible forms of patient selection. Therefore, nearly all the 
offspring in 30 pedigrees of Dutch families with at least two generations of members 
affected by osteogenesis imperfecta type I were subjected to a clinical examination, 
whereas for the calculation, the probands were excluded. 
The majority of the family members of the propositi were examined by the authors or 
sufficient data could be obtained. Ultimately, in about 10% of the offspring, we had to 
rely on data obtained via hetero-anamnesis, because the person in question had 
emigrated or was deceased. Several offspring were excluded from the analysis: two 
missed abortions, one abortion whose sex was known, two stillbirths with or without 
characteristics of the disease. 
Members of these families were diagnosed as having osteogenesis imperfecta type I if 
they had blue sclerae and a history of more than one fracture, whether or not in 
combination with hearing loss. Especially hearing loss occured in each family. 
A number of offspring had never sustained a fracture because of their young age, but 
on the basis of blue sclerae, a characteristic habitus, a clear family anamnesis and 
sometimes on the basis of other OI characteristics, they could be diagnosed as having 
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ΟΙ. 
The determination of blue sclerae is subjective. We did not use a colour chart, as 
Sillence et al.1 In cases where the colour blue was doubtful or the physician had 
otherwise recorded 'dubious', the sclerae were considered to be normal. 
In this study, hearing loss was defined as a mean loss of 15 dB (HL) or more at 0.5, 1 
and 2 kHz and/or a mean loss of 30 dB (HL) at 4 and 8 kHz in subjects of up to 50 
years of age; in subjects older that 50 years of age (possibly with presbycusis), hearing 
loss was defined as a mean loss of 20 dB (HL) or more at 0.5, 1 and 2 kHz and/or a 
mean loss of 35 dB (HL) at 4 and 8 kHz. 
We also investigated the hearing loss in the present population using the criteria of 
two earlier studies.131'' Pedersen (1984) considered a hearing threshold of 15 dB at 
any of the frequencies between 0.25 and 4 kHz to be a hearing loss, whereas Shapiro 
et al. (1982) applied the same limit to any of the frequencies between 0.25 and 8 kHz. 
In patients who were found to be hearing impaired but had undergone an ear 
operation owing to a different disease, the hearing loss was not attributed to 
osteogenesis imperfecta. Children younger than 6 years of age with otitis media with 
effusion were considered to have normal hearing. None of the sufferers had to be 
considered as hearing impaired on the basis of a reliable hetero-anamnesis. 
Dentinogenesis imperfecta was not included in this study as a diagnostic characteristic, 
because in retrospect, it was not possible to establish whether an edentulous patient 
had suffered from caries or dentinogenesis imperfecta in his or her youth. 
For each family pedigree, segregation and penetrance were analysed depending on 
whether or not male-to-male inheritance was present. They were also calculated for 
the separate generations in a smaller group of offspring, in which at least two 
consecutive and complete generations had undergone a thorough clinical examination. 
RESULTS 
In the total group of 144 offspring from 30 families whose members had been 
examined thoroughly, 103 (72%) were seen by the authors themselves or had 
undergone a clinical examination elsewhere at our request (n=25 (17%)) or enough 
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data were available on them. In 16 cases (11%) we had to make do with data from 
hetero-anamneses, because 9 of them were deceased, 5 had emigrated and 2 had lost 
touch with the family and were therefore unreachable. 
The group of 144 offspring comprised 79 men and 65 women (group I). Two 
subgroups were formed depending on whether male-to-male inheritance was present 
(group II) or absent (group III) (Table 1). Group II comprised 14 families with 78 
offspring (47 men and 31 women). Group III comprised 16 families with 66 offspring 
(32 men and 34 women). 
Segregation and penetrance were analysed per generation in 17 families with 107 
offspring, in which at least two consecutive generations had been examined thoroughly 
(Table 2). 
Segregation analysis 
On the basis of the above-mentioned criteria, 70 offspring (group I) were found to 
have osteogenesis imperfecta type I. For the cases with male-to-male inheritance 
(group II) and those without (group III), 40 and 30 were found to have osteogenesis 
imperfecta type I, respectively. The number of sufferers per decade are shown in 
Figure 1. 
In group I with 70 sufferers, the segregation was 70/72, in group II 40/39 and in group 
III 30/33. The male:female ratio in the 70 sufferers was 33:37. 
In the group where segregation was judged per generation, 51 persons were 
considered to be OI sufferers, i.e. the segregation was 51/53.5 (Table 2). There was 
very little difference between the segregation ratios in the first and second 
generations. In the third generation, only 7 sufferers were present. 
Penetrance 
Blue sclerae were diagnosed in 79 out of the 144 offspring (group I), of whom 4 by 
means of hetero-anamnesis. For 9 of these 79 offspring, it was not possible to confirm 
the diagnosis of OI using the usual criteria. 
The penetrance of blue sclerae in group I was 70/70 (100%) (Table 1). Similar 
penetrance was found in groups II and III. Figure 1 shows the penetrance per decade. 
Fractures were observed in 61 of the 144 offspring in group 1 (Table 1). Five healthy 
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Table 1: Segregation and penetrance analysis in the offspring of families with 































































* I, total population, II, families with male-to-male inheritance, III, families without male-to-male 
inheritance. 
Table 2: Segregation and penetrance per generation in the offspring of families 


















































































offspring with, as a rule, one fracture in their anamnesis were excluded. The 
penetrance of fractures in the total population was 61/70 (87%). The distributions in 
groups I, II and III were similar (Table 2). Figure 1 shows the penetrance per decade. 
Hearing loss was present in 30 out of the 144 offspring (Table 1). Seven healthy 
hearing impaired offspring were excluded. The penetrance of hearing loss was 30/70 
(43%); the ratios found in groups II and III were very similar. The calculations per 
generation showed an increase in the penetrance of hearing loss in the older 
generations (Table 2). Figure 1 shows the penetrance per decade. 
"When Pedersen's (1984) criteria for hearing loss were applied to our group, we found 
33 sufferers out of the 144 offspring, i.e. the penetrance was 33/70 (47%). When 
Shapiro's (1982) criteria for hearing loss were applied to our group, we found 35 
sufferers out of the 144 offspring, i.e. the penetrance was 35/70 (50%). 
Frequency of main symptoms 
in random offspring 
Number of patients 






- j Hearing loss 
Blue sclerae 
Figure 1: Segregation and penetrance per decade in the 144 random offspring of 
families with osteogenesis imperfecta type I. 
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DISCUSSION 
This study on 30 thoroughly examined family pedigrees whose members were suffering 
from osteogenesis imperfecta type I (McKusick no. 16620), comprised 235 family 
members with 144 random offspring, which offered the opportunity to perform 
segregation and penetrance analyses. It is peculiar that next to blue sclerae and 
fractures, also hearing loss occured in each pedigree. For 17 pedigrees, at least two 
complete generations could be thoroughly examined, and therefore analysis is also 
presented per generation. These data are of importance for genetic counselling and 
for later gene-linkage studies. 
The three criteria for making a clinical diagnosis of OI proved to be sufficiently 
reliable in the present study, provided they were clearly defined. Using the criteria 
separately might lead to overdiagnosis, because none of the three characteristics are 
specific to osteogenesis imperfecta. Particularly blue sclerae were observed a number 
of times in healthy offspring and it is obviously possible for nonsufferers to sustain 
fractures. Hearing loss remains an arbitrary matter: opinions differ as to the extent of 
hearing loss and the frequencies at which it should be considered abnormal. 
The segregation analysis in our random study group produced a ratio of 70:72, which 
is striking. When the offspring were divided into two subgroups depending on whether 
male-to-male inheritance was present, no significant shift was observed in the 
segregation and penetrance analyses. We can therefore conclude on the basis of our 
findings that in our study population there were no indications of two genetically 
distinguishable subtypes of osteogenesis imperfecta type I (McKusick no.16620) 
(Table 1). 
In family members in their first decade, we are faced with the risk of overdiagnosis 
because isolated cases of blue sclerae are fairly common in young children. However, 
in our study, we applied three criteria for OI diagnosis and thereby excluded this risk. 
There were no significant differences between the results of the segregation analyses 
in the separate generations (Table 2). 
For the analysis of the penetrance of the separate characteristics, we used sharply 
defined criteria. It was striking that neither the fact that the sufferers had blue sclerae 
nor the presence or absence of male-to-male inheritance had any influence on 
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penetrance (Table 1). In the total group of offspring, 9 others were found with blue 
sclerae, but they did not meet the remaining criteria for OI. Overdiagnosis seems to 
particularly apply to other studies in which blue sclerae was the only criterion.15,16 
The penetrance of fractures of 61/70 (87%) was a fairly constant factor, which was 
also found in groups II and III (Table 1) and in the first and second generations 
(Table 2). Only subjects who had sustained fractures were included; the number and 
frequency of the fractures were not taken into consideration. These data agreed with 
those reported in literature, regardless of which definition of fractures was used.17"19 
Age had only a slight influence on the penetrance of fractures. A difference was found 
between the first two decades (80%) and the other decades (100%), but the 
difference was small (Figure 1). 
The penetrance of hearing loss depended on the criteria used. In this study we chose 
a mean hearing loss, both for the frequencies 0.5, 1 and 2 kHZ and for 4 and 8 kHz. 
In addition, the threshold was raised for subjects older than 50 years of age. The 
penetrance of 30/70 (43%) was similar in groups II and III (Table 1). In the second 
decade, the penetrance of hearing loss increased, which shows that age plays a role in 
the progression of hearing loss (Figure 1). The increase in this penetrance value per 
generation makes it likely that penetrance increases with age (Table 2). We can also 
assume that after the third decade, the majority of sufferers who will ever be 
confronted with (invalidating) hearing loss, will have been recognised. The data in 
Figure 2, which were compiled on the basis of mean hearing thresholds for the 
frequencies 0.5, 1 and 2 kHz in all sufferers, show that after the third decade, very 
few ears had normal hearing thresholds. 
In order to find out how much Shapiro's (1982) and Pedersen's (1984) definitions of 
hearing loss would affect our findings, we applied their definitions to our data. Using 
Pedersen's definition for the penetrance of hearing loss, our ratio increased from 
30/70 (43%) to 33/70 (47%); using Shapiro's definition the penetrance was 35/70 
(50%). Contrary to the present study, in which a hearing loss was defined by means of 
mean values at various frequencies between 0.5 and 8 kHz, the other studies applied 
a definition of hearing loss in which only one frequency was stated and only one of 
the studies (Shapiro et al., 1982) included a frequency of 8 kHz. When we applied 
these two factors to our random Dutch study population, only a slight increase in the 
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penetrance of hearing loss was observed. Therefore, the effect of the various 
definitions was only very slight. 
Figure 2 shows the extent of hearing loss in our large random Dutch study population. 
It is striking that a considerable hearing loss was already present in the second 
decade. 
Further studies and presentations on the relationship between the extent of hearing 
loss and the penetrance may provide useful information and identify indicators which 
can predict the progression of the hearing loss in individual cases. 
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Figure 2: Plot diagram of the mean hearing thresholds of the Fletcher index (0.5, 
1, and 2 kHz) of both ears from 70 random osteogenesis imperfecta 
type I sufferers against age, per decade. 
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ABSTRACT 
Hearing loss was studied in relation to age in 142 subjects suffering with osteogenesis 
imperfecta type I. In order to estimate any selection these subjects were compared to 
a random subsample of 70 subjects with the same disease. It appeared that in the 
group of 142 subjects, particularly below the age of 30 years, considerable selection 
had occurred on hearing loss. 
The hearing threshold increased gradually with age. A hearing loss greater than 30dB 
was observed for 51% of the subjects older than 20 years and younger than 60 years. 
The median hearing loss increased from the 10th to the 45th year of life with an 
average of about IdB/year at the frequencies 0.5-4kHz and an average of 1.7dB/year 
at 8kHz. The sensorineural component of the hearing loss showed an average annual 
increase of 0.6dB (0.5-4kHz) up to 1.3dB (8kHz); the average annual increase in the 
conductive component of the hearing loss appeared to be 0.4dB at all frequencies. 
The sensorineural component was the major component in severe hearing loss. 
INTRODUCTION 
Over the past three decades, hearing loss has been reported as a major symptom of 
osteogenesis imperfecta.1"13 A variety of definitions of hearing loss and examination 
methods can be found in these reports.710,12·13 The groups of affected subjects 
examined do not usually represent random samples. 
Despite the frequently described progression of hearing loss with age, age has seldom 
been taken into account in the analyses of hearing loss caused by osteogenesis 
imperfecta. Obviously the progression and the extent of hearing loss heavily depends 
on the age of the affected subjects. The type of hearing loss may be conductive, 
sensorineural or mixed. 
The present study analyzes the type and extent of hearing loss related to age in a 
selected sample of 142 subjects affected by the autosomal dominant type I of 
osteogenesis imperfecta.14 The results are compared to those of a previous study on a 
random sample of 70 affected subjects, who also had osteogenesis imperfecta type I, 
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from fully examined sibships. 
PATIENTS AND METHODS 
With the assistance of a number of Dutch ENT surgeons and the Dutch Association 
of Patients with Osteogenesis Imperfecta, we were able to compile a series of 142 
subjects affected with osteogenesis imperfecta type I for this study. The clinical 
diagnosis was based on the medical history and clinical examination. Previous reports 
concerned the findings and the results of ear surgery in subsamples of the present 
series.15"17 The penetrance of hearing loss was studied in a random subsample of 70 
affected subjects, established by fully examining the sibships in 30 families with at least 
one affected subject in 2 generations.13 Only 60 of these 70 patients had undergone 
clinical audiometry. Of the other 10 patients, 2 were deceased, 6 were too young and 
2 were living abroad. None of the latter 10 patients were known as hard-of-hearing. 
Pure tone auditory thresholds (decibels hearing level) were obtained (from non-
operated ears) under standard conditions in a soundproof room at our clinic or 
elsewhere. Subjects younger than 4 years of age were excluded from this study. Also 
excluded were subjects with hearing loss that could be attributed to causes other than 
osteogenesis imperfecta, such as chronic otitis media. When several audiograms were 
available which had been measured at different ages, we took the one obtained at the 
youngest age. We used the following working definitions for the various types of 
hearing loss paralleling the definitions given by Shapiro et al.9 and Pedersen.10 
1. Conductive loss: average air-bone gap for the frequencies 0.5, 1 and 2kHz or 
else the average air-bone gap at 4 and 8kHz greater than 15dB; corresponding 
bone conduction threshold below 15dB. 
2. Sensorineural loss: average air conduction threshold equal to or greater than 
15dB at the frequencies as indicated above; corresponding air-bone gap smaller 
than 15dB. 
3. Mixed loss: average air-bone gap equal to or greater than 15dB at the 
frequencies as indicated above; corresponding bone conduction threshold equal 
to or greater than 15dB. 
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The synopsis on hearing loss and age presented in Tables 1 and 2 provides a 
comparison to the relevant literature.1"3,5"10'1213·18 The different types of hearing loss 
are shown in two age classes (Table 3). Detailed cross-tables (hearing loss by age) 
were composed for the present group of 142 subjects (Table 4) and the previously 
reported random subsample of 70 subjects belonging to the fully examined sibships, 
who were not selected for their hearing loss (Table 5),13 in order to make a direct 
comparison. 
The statistical test used was the chi-square test for a 2 χ 2 table, with the level of 
significance of ρ=0.05 (X2 value 3.84). Scatter plots were prepared for the data on 
hearing loss and age; details about the type of threshold data and the analyses 
involved are given where relevant. 
RESULTS 
The proportion of affected subjects having hearing loss and relevant data from the 
literature are presented in Table 1. The present study relates to the highest 
percentage (78%) of hearing loss reported so far. The exact application of the 
definitions of hearing loss given by Pedersen10 and Shapiro9 yielded 80% and 83% 
hearing loss, respectively, for the present series, which indicates that there are only 
slight differences between the definitions. The random (sub)sample reported by 
Garretsen & Cremers13 yielded a much lower percentage (43%) of hearing loss. 
It is remarkable that the family studies1"3,5"8 yielded a similar low percentage (90 of 
212 patients, or 42%). The latter studies, including the work by Garretsen & 
Cremers,13 indicate a mean percentage of 43% for hearing loss, which has a 
corresponding proportion of 120/282. This differs significantly from the other non-
family studies,9,10,12,18 for whom 502 of 769 patients (65%) are hard of hearing. Table 
2 shows the relation between the proportion of subjects with hearing loss among the 
affected subjects and the age of the subjects (in decades) for the present and some 
other relevant studies.5,7"10,12,13 For those below 30 years of age, hearing loss was 
observed for 96/268, or 36%. The present study, however, had a significantly higher 
proportion of subjects with hearing loss (54/82, or 66%). For those aged 30 years and 
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Note: The proportion of patients with hearing loss is presented with the percentage in parentheses. 
The definitions of hearing loss may differ. 
"Portable" means portable equipment and implies less accuracy than usual. 
"75% Pop." refers to 75% of the Danish population. 
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Table 2: Survey of studies on hearing loss in osteogenesis imperfecta as 





































































































































Note: The proportion of patients with hearing loss within a given age-class is presented. 
Percentage in parentheses (only for n>4). 
• Original classes 1st - 3rd decades and 4ih - 7th decades. 
** Interpretated from the original figures. 
older, the present study and the one by Shapiro et al.9 had higher proportions of 
hearing loss (57/60 or 95%, and 17/18 or 94%, respectively) than the other selected 
groups of patients,1012 which showed an average proportion of 87/109 (80%). The 
proportions corresponding with 94-95% are significantly higher than those for all the 
family studies5,7,8,13 taken together, which yielded a proportion of subjects with hearing 
loss of only 38/66 (58%). The data in Table 2 clearly show that the proportion of 
subjects with hearing loss increases with age. This is particularly clear in the larger 
series. An exception is the series published by Garretsen & Cremers,13 which showed 
large deviations from the general trend in the 2nd and the 4th decades. Together with 
the present series, of which it represents a subsample, the series by Garretsen & 
Cremers13 differs significantly from the others in the high proportion of hearing loss in 
affected subjects in their second decade of life. 
The statistics for normal hearing and the various types of hearing loss are presented 
in Table 3, including two age classes. Normal hearing was most frequent at a younger 
age. Conductive loss was found only in a few young affected subjects. Mixed hearing 
loss was the most frequent type of hearing loss and the frequency increased 
significantly with age. Constant proportions, independent of age, were found for 
sensorineural hearing loss, Shapiro's CHOI9 and deafness. 













52 ( 34) 
3 ( 2) 
56 ( 37) 
27 ( 18) 
10 ( 7) 
3 ( 2) 
151 (100) 
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3 ( 1) 
145 (51) 
52 ( 18) 
17 ( 6) 
5 ( 2) 
282»* (100) 
Note: Percentage in parentheses 
* Hearing loss characteristic for OI (CHOI) according to Shapiro et al.1 
** Data not apllicable for one ear in two cases 
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Table 4 is a cross-table of air conduction thresholds by age (in decades) for the 
proportion of ears with a given hearing loss in the present series of selected subjects. 
Table 5 is a similar table for the random subsample.13 In Tables 4 and 5, the median 
hearing loss per decade is also presented. In the present selected sample, the median 
hearing loss increased from the 1st decade from 0-10dB up to about 30dB in the 3rd 
decade (Table 4). In the random sample (Table 5), the median hearing loss only 
increased after the fourth decade. In the selected sample the air conduction threshold 
was higher than 30dB for (85/166) 51% of the affected subjects 20-59 years of age 
(Table 4); a further (significant) increase in this proportion could only be noted in the 
seventh decade. Testing the proportions in the cells for 0-10dB and the second or 
third decade in the random sample (Table 5) against the corresponding proportions in 
the selected sample (Table 4) showed that the random sample had significantly higher 
proportions in these cells (pertaining to 58% as compared to 47% and to 70% 
compared to 27%, respectively, see Tables 4 and 5). 




























































1/16 ( 6 ) 
13/16 (81) 
Note: Proportion of 284 cars within a given class of hearmg loss (dB HL, Fletcher-index) in decades 
Percentage in parentheses 
The shading indicates the median hearing loss per age class 
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The difference in the relationship between the air conduction threshold and age 
between the two series (random and selected cases) appeared to be significant. With 
increasing age, the two series tended to develop a similar (median) hearing loss, but 
the series of selected cases showed selection especially at a younger age. For each 
pair of corresponding cells in Tables 4 and 5, we calculated the difference between 
the random and the selected samples. In this way we obtained a two-dimensional 
distribution which showed a surplus in proportion compared to the random sample 
(Table 5) in the following cells: 35-50dB/10-19yrs (9/24 or 38%); 55-90dB/10-19yrs 
(6/24 or 25%); 35-50dB/20-29yrs (19/40 or 48%). For the three cells combined, the 
difference distribution indicated a proportion of 34/64 (53%), while this combination 
for the random sample (Table 5) yielded a proportion of only 11/72 (15%); the 
difference is significant. The difference distribution had a median threshold for all age 
classes beyond the first decade which coincided almost invariably with the class 35-
50dB. 
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4/ 6 (67) 
1/6(17) 
Note: Proportion of 118 ears within a given class of hearing loss (dB HL, Fletcher-index) in decades 
Percentage in parentheses (only for n>4) 
The shading indicates the median hearing loss per age class. 
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In order to establish further characteristics of the hearing loss as it develops with age, 
we prepared separate scatter plots for the present series, for air conduction, bone 
conduction and air-bone gap at all the frequencies. Those for the mean hearing loss at 
0.5, 1 and 2kHz are depicted in Figures 1 through 3. 
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Figure 1: The mean air conduction threshold (dB HL, Fletcher Index) in the 
selected group (282 ears) plotted against age (years). 
Note: The numbers in the figure (n<10) correspond with the number of ears with a given 
combination of a certain hearing loss and age at the appropriate coordinates. The 
histogrdm-likc contour represents the interconnected median values for hearing for 
age classes (width 2 years) covering 10-45 years of age (10-11, 12-13, ., 42-43, 
44-45 years) 
The linear "regression" of this "biennial" median hearing loss on age has been visually 
estimated and the resulted regression lins is drawn (continuous sloped line). It 
indicates the general trend from 10 dB at 10 years towards 45 dB at 45 years. 
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In the plots we have indicated the median hearing loss (class width 2 years in order to 
obtain n>4 for a reliable estimation of the median). It can be seen from Figures 1 
through 3 that we utilized the median values to estimate the linear "regression" of 
hearing loss on age (continuous sloped line). It should be noted that this "regression 
analysis" was limited to the age range 10-45 years for the following reasons: 
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Figure 2: The mean bone conduction threshold (dB HL, Fletcher Index) in the 
selected group (282 ears) plotted against age (years). 
Note: See fig. 1 for legend. 
The regression line indicates the general trend from 5 dB at 10 years towards 25 dB at 
45 years. 
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In the age groups younger than 10 years and older than 45 years of age, there 
were relatively few data available, especially regarding bone conduction and 
air-bone gap, i.e. a class width >2 years would be required in order to obtain 
n>4; 
This particular age range showed the most prominent increase in hearing loss; 
The distributions of the air and bone conduction thresholds at 4 and 8kHz, 
particularly in the older patients, appeared to be bimodal, analogous to 
otosclerosis,19 which would complicate a meaningful analysis. 
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Figure 3: The mean air-bone gap (dB HL, Fletcher index) in the selected group 
(282 ears) plotted against age (years). 
Note: Sec fig. 1 for legend. 
The regression line indicates the general trend from 5 dB at 10 years towards 20 dB at 
45 years. 
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The results of the analysis are presented in Table 6 and yields the following results for 
the selected group. 
1. The sensorineural component of hearing loss increased with both age and 
frequency; 
2. The conduction component increased with age, to a similar degree for all 
frequencies; 
3. The major increase in hearing loss was invariably shown by the sensorineural 
component: 0.6dB/yr for the mean of 0.5, 1 and 2kHz, 0 7dB/yr at 4kHz and 
1.3dB/yr at 8kHz. The increase in air-bone gap with age was limited to about 
0.4dB/yr. 
Table 6: Median hearing loss and progression of hearing loss 
in 142 patients with osteogenesis imperfecta type I. 
Age 



































20/35 = 0 6 
15/35 = 0 4 
35/35 = 1 
25/35 = 0 7 
15/35 = 04 
40/35 = 1 1 
45/35 = 1 3 
15/35 = 04 
60/35 = 1 7 
Note Median hearing loss (dB HL) for 142 selected patients with osteogenesis imperfecta 
type I at the age of 10 and 45 years, for the mean at 0 5, 1 and 2kHz, for 4kHz, 
and for 8kHz, for air conduction, bone conduction and air bone gap, together with 
the calculated progression (dB/yr) 
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DISCUSSION 
The present report on a group of 142 selected subjects with osteogenesis imperfecta 
type I shows the highest proportion of hearing loss reported so far. A comparison with 
the random sample,13 which formed part of this series, showed that considerable 
selection on hearing loss had taken place at a rather young age. It is interesting to see 
that the median hearing loss of the distribution of the difference between the selected 
and the random samples, i.e., which relates to the group of affected subjects who were 
selected for ear surgery because of their hearing loss, coincides with the class of 30-
50dB loss in air conduction threshold at any age from 10 years onwards. Apparently, 
the presumed selection has taken into account that a Fletcher index of more than 
30dB renders the hearing capacity socially ineffective. 
The findings relating to Table 1 suggest the possibility that the family studies concern 
series of patients which are more similar to a random sample than to a selected 
sample. Therefore, it seems justified to consider the prevalence of hearing loss in 
osteogenesis imperfecta type I as being 43%. It appears from Table 2 that the series 
with selected patients distinguish themselves especially by a greater hearing loss at an 
increasing age (30 years and older). In the present series, the proportion of subjects 
with hearing loss was higher than in any other series published so far, also at a 
younger age. It may be relevant that the "self-selection" of affected subjects with 
hearing loss played a role, because a patient association lent its active support to the 
present study. 
When comparing the present selected sample (Table 3) to other selected samples, as 
far as possible, as regards the type of hearing loss, the present series included more 
cases of mixed hearing loss, especially in the older patients, than the series published 
by Shapiro et al.9 and Pedersen.10 The present series also showed considerably more 
sensorineural loss (only) at a young age as compared to Shapiro et al.9 and 
Pedersen.10 This only holds true as regards the comparison with Shapiro et al.9 if 
CHOI is set apart. This type of hearing loss, that was found by these authors in both 
the lower and higher age groups in 47% of the ears, was only found in a minor 
percentage by us (Table 3), as well as by Pedersen.10 Others have also found that the 
predominant type of hearing impairment in osteogenesis imperfecta was the mixed 
type, although to a much lesser degree than in the present study.5,7,8,12 Stewart & 
O'Reilly12 and Riedner et al.7 indicated that conductive loss, as far as it was present, 
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prevailed in the younger age group. Stewart & O'Reilly,12 just as we did, described an 
age-independent proportion for the sensorineural type of hearing loss. 
The present series showed gradual progression in hearing loss with age. A 
considerable increase in the hearing loss took place especially from the 10th to the 
45th year of life, which comprised a considerable increase in sensorineural hearing 
loss and only a limited increase in conductive loss (Table 6). We studied individual 
follow-up data covering 2 through 24 years (average 9.6 years) on all the subjects who 
had ear surgery.16 Between 1 and the average 9.6 years after operation, the mean 
hearing level in the operated ear dropped by 6.5dB, which almost equals the 
indication given in Table 6, despite the fact that the conductive component in 
postoperative hearing loss plays a lesser role. Also the non-operated ear showed a 
similar progression in hearing loss.16 
It was intriguing to see that the increase in air-bone gap seemed to be limited to 
about 0.4dB/yr, independent of the sound frequency. 
Less than 50% of the affected subjects older than 20 years of age had averages of 30 
dB (Fletcher index) or better, also called "social hearing". From two previous 
reports15,16 it appeared that among 58 operated ears, there was only one ear with 
social hearing, preoperatively. Postoperatively, 24 ears (41%) did not reach the level 
of social hearing. The above evaluated progression of hearing loss with age, as already 
stipulated, occured in both the non-operated and the operated ear and to a similar 
degree.17 The average hearing gain immediately after the operation was about 24dB 
(see Garretsen & Cremers,16 Table 4), thus, given the progression in hearing loss such 
as presented in Table 6, the hearing gain tends to "disappear" after a follow-up 
interval of several decades, as indeed seemed to be the case in the patients with a 
long enough follow-up. In addition, it should be realised that the patients have an 
artificial sound transmission mechanism after the operation and that the postoperative 
hearing gain is mainly of the conductive type. Therefore, the expected yearly 
conductive hearing loss of 0.4dB does not apply anymore to operated ears. In this 
way, on the one hand, the postoperative hearing gain will remain intact over a period 
which is longer than the period on analogy with a deterioration of IdB/yr. On the 
other hand, however, the progression of sensorineural hearing loss of operated 
patients may be more than in non-operated patients. From an earlier study it became 
clear that a relatively greater preoperative sensorineural hearing loss was present 
particularly in the patients who were operated on at a young age.17 It is possible that 
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in this group of patients, the progression of sensorineural hearing loss which occurs 
pre- and postoperatively is greater than in the average patient. 
It seems justified to advise the affected subjects to avoid, if possible, the choice of a 
type of profession which depends heavily on auditory communication. 
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STAPES SURGERY IN OSTEOGENESIS IMPERFECTA 
С W.R.J. Cremers and A.J.T.M.Garretsen 
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ABSTRACT 
Between 1968 and 1986 stapes surgery has been performed in the Nijmegen 
University Department of Otorhinolaryngology in 11 patients (14 ears) with 
osteogenesis imperfecta. Detailed information about pre- and postoperative hearing 
levels, findings at surgery, and the follow-up period are presented. In most cases the 
stapedectomy has been successful. 
INTRODUCTION 
In 1917 Van der Hoeve and De Юеуп from the Netherlands were the first to report 
hearing loss in several members of a family with osteogenesis imperfecta.1 The 
relationship between blue sclerae and brittle bones had been noted for the first time a 
few years previously. Osteogenesis imperfecta forms a group of diseases with an 
anomaly in collagen synthesis, well known because of the brittle bones. Recently, 4 
major forms of osteogenesis imperfecta have been recorgnized, which have been 
further subdivided. Autosomal dominant and autosomal recessive patterns of 
inheritance are possible.2^ Shapiro et al5 mentioned that a hearing loss, most 
frequently sensorineural, occurred in 49% (younger than 30 years) and 94% (older 
than 30 years) of patients with osteogenesis imperfecta. 
A distinct sensorineural hearing loss at 6 and 8 kHz has recently been reported as a 
new additional feature.5 The hearing loss is mostly small and can be located in the 
middle ear, the inner ear or both. For a long time osteogenesis imperfecta was 
considered to be a more serious form of otosclerosis. This concept has been proved to 
be incorrect. Stapes surgery in osteogenesis imperfecta has been considered to be 
more risky than in otosclerosis. 
PATIENTS AND METHODS 
In the period 1968 to 1986 11 patients with osteogenesis imperfecta underwent stapes 
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surgery in the Nijmegen University Department of Otorhinolaryngology; in three 
patients surgery was bilateral. In all 14 ears, the stapes was replaced by an all-teflon 
0.6 mm or a teflon-wire 0.4 mm prosthesis. The pre- and postoperative hearing level 
and the hearing gain are presented separately for each ear in Figure l.a and l.b. The 
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Figure 1л: Results of 14 stapedectomies in osteogenesis imperfecta in terms of the 
average pure-tone threshold (in dB, HL) for the frequencies 0.5, 1, and 
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Figure l.b: Results of 14 stapedectomies in osteogenesis imperfecta in terms of the 
average pure-tone threshold (in dB, HL) for the frequencies 0.5, 1, and 
2 kHz. AD indicates right ear; as, left ear. 
RESULTS 
Fractured stapes crura were seen in three ears and atrophy of the stapes crura in 
another three ears (Table 1). Disturbing hemorrhage of the mucosa and/or stapes 
footplate was noted in six ears. In all of these ears, the footplate was found to be 
fixed. Thick brittle footplates were seen in 10 ears. 
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Table 1: Findings during stapes surgery in 14 ears from 11 patients with 
osteogenesis imperfecta. 
Findings at operation 
Footplate 
Fixed 






















The air-bone gap was closed to within 10 dB in 12 of the 14 ears. It is striking that in 
5 of these 12 successfully operated ears an air-bone gap of 10 dB was achieved. It is 
an open question whether these small air-bone gaps distinguish this disease from 
otosclerosis. The case operated in 1968 has an air-bone gap of 15 dB. A recent case 
with bilateral, almost total deafness did not improve after stapes surgery. Dizziness 
after surgery was only a temporary complication. 
DISCUSSION 
About 50% of the persons with osteogenesis imperfecta will experience a hearing loss 
during their lives. This hearing loss is progressive. There can be a conductive and a 
sensorineural component. This hearing loss can be so progressive that it can result in 
total deafness. Since many of these patients are already more or less handicapped by 
their disease, the otologist's major concern may therefore be an improvement of their 
hearing. Since in the past, osteogenesis imperfecta was considered to be a more 
serious form of otosclerosis, fear of complications led to some hesitation to embark 
upon stapes surgery. 
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After the period that fenestration of the lateral semicircular canal had been 
performed, the first report of a succesfull stapedectomy in osteogenesis imperfecta 
was given by Sooy in 1960. Since then a series of reports on stapes surgery in 
osteogenesis imperfecta have been published.6"19 Most of these reports concerned case 
reports or small series. In the late seventies the first reports on 10 stapedectomies or 
more have been published.12'17 Previous reports on dead ears after stapedectomy had 
been published in small series by several authors.9"11 Brosnan et al12 described one 
dead ear after 10 stapedectomies. Shea and Postma1" reported a complete 
sensorineural hearing loss for 2 out of 24 cases with long-term results (11%). Of the 
51 cases with a one year follow-up only these two had a decrease in their hearing 
(4%). Pedersen and Elbrond13,15 reported no dead ears after stapedectomy in 43 ears. 
Our series of 14 stapedectomies also did not show any increased postoperative 
sensorineural hearing loss. One of our patients experienced a progressive deafness 
over several decades resulting in complete deafness of one ear and almost complete 
deafness of her best ear. Stapedectomy has not been successful in improving her 
hearing. 
We preferred to present our results the way Pedersen and Elbr0nd13'15 presented 
theirs. By using this method detailed information can be given in a few tables for each 
ear of larger series. The results of Shea and Postma,14 Pedersen and Elbrtfnd,13,15 and 
our own results show that a small air-bone of about 10-15 dB for 500-2,000 HZ 
postoperatively is not so unusual. The air-bone gap was closed in our series to within 
10 dB in 12 of the 14 ears. It is striking that in 5 of these 12 successfully operated 
ears an air-bone gap of 10 dB was achieved. The question remains whether these 
small air-bone gaps distinguish this disease from otosclerosis. 
Our study supports the concept that osteogenesis imperfecta is clinically different 
from otosclerosis. Considering these results we conclude that surgical intervention for 
the conductive hearing loss in osteogenesis imperfecta is a reasonable alternative to 
amplification. Although the surgical results in osteogenesis imperfecta are good, they 
are possibly not as good as in otosclerosis. 
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ABSTRACT 
Preoperative and postoperative hearing results and long-term results of stapedectomy 
have been investigated in 58 ears (47 patients) with osteogenesis imperfecta. 
After 3 months hearing gain had been achieved in 49 (85%) of 58 ears. 
Twenty-seven (68%) of 40 ears followed up for an average of 9.6 years (range, 2 to 24 
years) had no deterioration of their immediate postoperative hearing gain. 
In the other ears, the decrease in hearing gain in the long term was due to 
progression of the sensorineural component of the hearing loss. Complete closure of 
the air-bone gap remained unchanged in 26 (70%) of 37 ears. 
In 6 (10%) of 58 ears the sensorineural component of the hearing loss increased as an 
immediate result of the operation. 
In 5 other ears (9%) progressive sensorineural hearing loss was seen only after more 
than one year. A natural course of the disease is assumed as the cause because 
progressive sensorineural hearing loss has also been seen in the non-operated 
contralateral ears of these patients. 
INTRODUCTION 
Osteogenesis imperfecta forms a group of diseases with an anomaly in collagen 
synthesis. This disease is renowned because of brittle bones. Recently, four major 
forms of osteogenesis imperfecta have been recognised and have been further sub-
divided.1 3 Autosomal dominant and autosomal recessive patterns of inheritance are 
possible. The autosomal dominant inherited type I, formerly also called osteogenesis 
imperfecta tarda, is the most frequent. In 1917 Van der Hoeve and De Kleyn4, from 
the Netherlands, were the first to report hearing loss in several members of a family 
with osteogenesis imperfecta tarda, with an autosomal dominant pattern of 
inheritance. Independently in 1917, Bronson5 also reported the same triad of blue 
sclerae, brittle bones, and hearing loss in 19 cases. Shortly thereafter, the British 
otologist Fraser6 examined these 19 patients and concluded in 1919 that there was a 
conductive hearing loss in some of these patients. The promontory tympani, 
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transparent behind the tympanic membrane, showed a somewhat darkly red-colored 
aspect, as seen in seriously affected cases with otosclerosis and which is known as the 
Schwartze sign. 
The hearing loss is mostly small and can be located in the middle ear, the inner ear, 
or both. For a long time osteogenesis imperfecta was considered to be a more serious 
form of otosclerosis. This concept has been proved to be incorrect. 
Stapes surgery in osteogenesis imperfecta has been considered to be more risky than 
in otosclerosis. After the period when fenestration of the lateral semicircular canal 
was performed,7"12 the first report of a successful stapedectomy in osteogenesis 
imperfecta was given by Sooy12 in 1960. Since then, a series of reports on stapes 
surgery in osteogenesis imperfecta has been published. Most of these reports were 
case studies or small series.n"17 Since the late 1970s, the first reports on 10 or more 
stapedectomies have been published.18"23 In 1982, Shea and Postma20 published the 
largest series, 62 operated ears in 43 patients. Their hearing results were presented 
for only 51 ears with at least a 1-year follow-up. This was followed by Pedersen24 in 
1985 with surgical reports of 43 ears in 32 patients. The series of 62 cars discussed in 
this article, all from patients in the Netherlands, is as large as the two preceding 
reports. The short-term and long-term results of investigations of this series will be 
presented in detail. 
PATIENTS AND METHODS 
This study of the results of surgery on the ears of patients with osteogenesis 
imperfecta is part of a much wider study of the nature of the hearing loss and the 
degree of progression of that loss. First, the results of stapes surgery in patients with 
osteogenesis imperfecta in the University Hospital Nijmegen Department of 
Otorhinolaryngology were collected and published.23,25 To this study could subse-
quently be added patients, known to other ear, nose, and throat surgeons in the 
Netherlands, who had also undergone ear surgery.26 An association of patients in the 
Netherlands with osteogenesis imperfecta (VOI) has also given its support in contac-
ting new patients. These activities started in 1984 and have now resulted in a series of 
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62 ears in 49 patients who have undergone ear surgery for osteogenesis imperfecta. 
For all patients, no distinction is made between osteogenesis imperfecta congenita and 
osteogenesis imperfecta tarda or any other subclassification in the diagnosis.1"3 
In 58 of these 62 ears, stapes surgery had been performed; in 2 of them, a 
fenestration of the semicircular canal had been performed, and in 2 of them, a 
replacement of the incus was performed. Almost all patients could be followed up and 
have been visited to obtain a highly detailed medical history. Pre- operative and 
postoperative audiograms and the surgical reports were gathered from the patient's 
medical files. Since many otologists have been involved over a long period of time, not 
all of the details we sought were available. Also, the methods of stapedectomy were 
different. Most patients could be traced personally and assisted in providing new 
audiometrie data, thereby increasing the duration of their follow-up period. 
We present data concerning the preoperative and postoperative hearing levels, the 
immediate postoperative hearing gain, the hearing gain at follow-up, and the 
increased postoperative sensorineural hearing loss. Long-term results in terms of 
average pure-tone hearing thresholds at 0.5, 1, and 2 kHz are also given and are 
related to the period of follow-up in months. 
RESULTS 
This study describes 31 women between the ages of 21 and 66 years (mean, 39.4 
years) and 18 men between the ages of 16 and 62 years (mean, 38.0 years). Of these 
49 patients, 10 had hearing loss unilaterally. Conductive or mixed hearing loss 
bilaterally was present in the remaining 39 patients. Eleven patients underwent 
stapedectomy bilaterally. Two of those 49 patients had a fenestration of the lateral 
semicircular canal and two others also had an incus interposition. Of those four pa-
tients, two have had a stapedectomy in the other ear, making a total of 58 
stapedectomies, of which 17 were performed at the Department of Otorhinolaryngo-
logy, University of Nijmegen. 
The mean age for the onset of hearing loss in 43 patients was 18.4 years. For 4 of 47 
patients, the age at onset of the hearing loss remains unknown. In 27 women, the 
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onset of hearing loss occurred between 5 and 37 years of age (mean, 16.1 years of 
age); for 16 males, the onset of hearing loss occured between 7 and 46 years of age 
(mean, 21.8 years of age). The mean age at the time of the first stapedectomy was 
30.6 years. Thirty-one women underwent surgery between 10 and 63 years of age 
(mean, 30.4 years of age), and 18 men underwent surgery between 16 and 50 years of 
age (mean, 31.6 years of age). 
The hearing results of 44 of 58 stapedectomies are illustrated in Figures 1 through 3. 
For 2 operations (ears 43 and 44) the preoperative audiogram could no longer be 
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Figure 1: Results of stapedectomy in osteogenesis imperfecta for patients 1 
through 14 in terms of the average pure-tone threshold (in decibel 
hearing level) for the frequencies 500, 1000, and 2000 Hz. AD indicates 
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Figure 2: Results of stapedectomy in osteogenesis imperfecta for patients 15 
through 28 in terms of the average pure-tone threshold (in decibel 
hearing level) for the frequencies 500, 1000, and 2000 Hz. AD indicates 
right ear; AS, left ear. 
For 14 ears in 11 patients with osteogenesis imperfecta who underwent stapes surgery 
in the period from 1968 through 1986 at the Department of Otorhinolaryngology at 
our hospital, the preoperative and postoperative hearing levels have already been 
published.25 The order of presentation of the results in that article corresponds with 
Nos. 45 to 58, inclusive of the operated ears in the present study. All of the other 
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Figure 3: Results of stapedectomy in osteogenesis imperfecta for patients 29 
through 44 in terms of the average pure-tone threshold (in decibel 
hearing level) for the frequencies 500, 1000, and 2000 Hz. AD indicates 
right ear; AS, left ear. 
SHORT-TERM RESULTS (3 AND 12 MONTHS) 
Hearing gain 
In Table 1, our results are compared with those of the earlier American and Danish 
series.20,24 Because of the compatibility with the Danish study, we decided to present 
the results in 58 easrs after 3 months. To be able to compare data with the American 
study, the results of stapes surgery after 12 months in 46 ears are also presented. 
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Table 1: Hearing results 3 and 12 months after stapes surgery 
This study 



















































Note: NA indicates not applicable for lack of data 
* Inclusive hearing improvement less than 10 dB. 
Table 2: Air-bone gap 3 and 12 months after stapes surgery 
This study 




















































Note: NA indicates not applicable for lack of data 
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Three months after the operation, 49 (85%) of 58 ears in which stapes surgery had 
been performed showed a hearing gain of more than 10 dB. In 5 ears (Nos. 14, 34, 
36, 37, and 57)(9%) the preoperative hearing threshold was increased by less than 10 
dB, or was unchanged. Furthermore, 3 of these ears (Nos. 34, 36, and 37) showed a 
considerable increase in hearing loss more than one year after the operation. In one 
ear (No. 57) deafness persisted unchanged. One ear (No. 14) showed a slight increase 
in the perceptive component, directly related to the operation. 
The hearing in four ears (Nos. 9, 26, 27, and 44)(7%) deteriorated within the first 
post-operative year. Three of these (Nos. 9, 26, and 44) showed a considerable 
increase in perceptive hearing loss with an almost totally closed air-bone gap directly 
after the operation. In another ear (No. 27) there was an isolated increase in the air-
bone gap with an unchanged perception threshold directly after the operation. Within 
one year, this patient had developed a perception loss with stabilization of the air-
bone gap to the preoperative value of 20 dB. 
After 12 months, 37 (81%) of 46 ears showed a hearing gain of more than 10 dB 
above the preoperative hearing threshold. In 5 ears (Nos. 14, 34, 36, 37, and 
57)(11%), the postoperative gain was less than 10 dB, or there was no change. These 
5 ears showed the same hearing characteristics after 3 months. The hearing in 4 ears 
(Nos. 18, 26, 27, and 44)(9%) had deteriorated. In 3 ears (Nos. 26, 27, and 44), there 
was no change in the situation after 3 months postoperatively. Ear 9 has not yet been 
studied for 12 months and is, therefore, not discussed here. Despite an initial hearing 
gain in ear 18, considerable increase in perception loss occurred within the first year 
postoperatively. In comparison with the preoperative condition, the hearing threshold 
is, therefore, reduced. 
Air-bone gap 
Table 2 compares the size of the air-bone gap in this study with the results from the 
American and Danish studies. 
After 3 months, 37 (71%) of 52 ears in our series showed a completely, or almost 
completely, closed air-bone gap (less than 10-dB difference between bone and air 
conduction). In 11 (21%) of these 52 ears, there was a direct postoperative air-bone 
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gap of 10 to 20 dB. In 3 ears (Nos. 29, 30, and 39)(6%) this value was between 20 
and 30 dB. There was a conductive loss of more than 30 dB in 1 (No. 27)(2%) of the 
52 ears. 
After 12 months, 31 (78%) of 40 ears showed a completely, or almost completely, 
closed air-bone gap following stapes surgery. In 5 (13%) of these 40 ears, an air-bone 
gap of 10 to 20 dB persisted, and in 4 ears (10%), the gap was 20 to 30 dB. There 
was some further improvement in the air-bone gap in our series between 3 and 12 
months. 
Incomplete data 
Partly because of the extent of the hearing loss in six ears from four patients, it is no 
longer possible to establish if there was an air-bone gap after 3 and 12 months. These 
ears (Nos. 34, 36, 37, 43, 44, and 57) are, therefore, excluded from Table 2. It is 
known that two of these ears (Nos. 34 and 37) from the same patient showed no 
change in hearing during the first year postoperatively. Audiometrie details for calcu-
lating air-bone gaps were unavailable. Another patient (ear 36) showed a subjective 
improvement in hearing postoperatively. However, the first postoperative 
measurement known to us took place after 5 years, which, after a steadily progressive 
hearing loss, established a completely deaf ear. One patient (ear 57) had become 
steadily deaf in both ears. Audiograms over a period of almost 30 years show 
considerable progression in her hearing loss. There was uncertainty with regard to the 
extent of the loss of perception. Nonetheless, the worst ear had undergone an opera-
tion in the hope that, after reduction of the conductive loss, some useful sensorineural 
remnants of hearing would become available. However, this stapedectomy was not 
followed by any improvement. From another patient who underwent stapedectomy 
bilaterally (ears 43 and 44), no preoperative or immediate postoperative audiograms 
are available. However, after 21 years the air-bone gap is closed bilaterally. 
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LONG TERM RESULTS 
Hearing gain 
Long-term results are available for 40 ears in which stapes replacement surgery was 
performed. The follow-up period varies from 2 to 24 years with an average of 9.6 
years (Table 3). A hearing gain of more than 10 dB above the preoperative threshold 
was present in 27 (68%) of the 40 ears. The decline in hearing gain from 85% after 3 
months to 68% in the long-term follow-up period is hardly the result of changes in the 
airbone gap. After 3 months, 71% of the ears showed a closed air-bone gap, falling to 
70% over a longer period. A gradual increase in perception loss during the follow-up 
period, as shown in Figures 1 through 3, would appear to explain this loss in hearing 
gain. 
Table 4 shows the average hearing gain for both the 3-month and the 12-month 
postoperative period and for the long-term follow-up. The results are compared with 
those from the Danish series. Despite incomplete data in the American series, 
extrapolation shows a global hearing gain in the period after 12 months. 
Table 3: Hearing gain and air-bone gap after stapes surgery. 
Long-term results 
This study 






































Note: NA indicates not applicable for lack of data. 
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Table 4: Mean hearing gain at 3 and 12 months postoperatively and long-term 
This study 


























Note: Mean value: 0.25, 0.5, 1, and 2 kHz; HL indicates hearing level. 
NA indicates not applicable for lack of data. 
* Extrapolation. 
In the follow-up period, 5 (13%) out of 40 ears showed unchanged hearing or a 
hearing gain of less than 10 dB when compared with the preoperative hearing 
threshold. After an initial hearing gain that persisted for some years, 4 of these 5 ears 
(Nos. 30, 39, 42, and 46) developed long-term perception loss with an unchanged air-
bone gap. The other ear (No. 57) with an unchanged hearing threshold remained 
deaf, whereby the perception threshold could not be measured, as had been the case 
preoperatively. 
Air-bone gap 
Long-term data regarding the air-bone gap are available for 37 of 40 ears. In the 
other 3 ears (Nos. 34, 36, and 55), the extent of the hearing loss makes it impossible 
to determine the perception threshold, and these ears are, therefore, excluded from 
Table 3. 
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Table 5: Mean air-bone gap preoperatively and postoperatively at 3 and 
12 months and long-term 
This study 


























Note: Mean value: 0.25, 0.5, 1, and 2 kHz; HL indicates hearing level. 
NA indicates not applicable for lack of data. 
Twenty-six (70%) of 37 ears have a completely, or almost completely, closed air-bone 
gap in the follow-up period. In 7 ears (19%), there is an air-bone gap of 10 to 20 dB. 
This figure is between 20 and 30 dB in 2 ears (Nos. 39 and 42)(5%). A conductive 
loss of more than 30 dB is present in 2 (Nos. 30 and 37)(5%) of 37 ears. It can be 
seen from Figures 1 through 3 and from Tables 2, 3, and 5 that the follow-up value of 
the air-bone gap shows little change from the direct postoperative phase. 
Increase in sensorineural hearing loss 
During the follow-up period, of 58 ears 11 (Nos. 9, 14, 18, 26, 27, 34, 36 through 38, 
40, and 44) showed a perception loss of 10 dB or more when compared with the 
preoperative perception threshold. This increase in perception loss appears to be 
directly related to the operation in six ears (Nos. 9, 14, 18, 26, 27, and 37). In two 
(Nos. 9 and 37) of these six ears, a floating footplate occurred as a complication. In 
two ears (nos. 26 and 27) with a massive and bony footplate, a vestibulotomy had 
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been performed at the edge of the oval window. This has not been of help to us in 
the removal of the very thick footplate. Postoperatively, the hearing levels deterio-
rated. The other two ears (Nos. 14 and 18) showed no intraoperative complications. 
In five ears (Nos. 34, 36, 38, 40, and 44), the progressive perception loss is not directly 
related to the operation, occurring more than one year thereafter, so that it is quite 
likely that an increase in the perception loss would have occurred whether or not an 
operation had been performed. In two ears (Nos. 18 and 37), there is a clear 
progression of the perception loss both in direct relation to the operation and during 
the follow-up period after one year. 
The observation that a progressive perception loss can arise unrelated to stapes 
surgery is supported by the occurrence of such a loss of perception in both ears. From 
four of five cases mentioned above (Nos. 34, 36, 38, 40, and 44), the contralateral ear 
also shows such a loss of perception. The late deafness in the fifth ear (No. 40) is the 
result of direct external trauma. A slight increase in the perceptive threshold can be 
seen in six other ears (Nos. 21, 30, 39, 41, 48, and 52). 
OTHER EAR OPERATIONS 
As well as 58 stapedectomies, we also saw the results of two fenestrations and two 
incus replacement procedures in four patients. Two of these patients underwent a 
stapedectomy in the other ear (Nos. 21 and 40). The fenestration operations were 
performed in 1948 and 1953 and led to no subjective improvement or deterioration in 
the hearing threshold (Figure 4). Audiometrie data could no longer be traced. The 
audiograms made during the last 20 years in these patients show a gradually 
progressive perceptive hearing loss of 20 dB with an unchanged air-bone gap 
averaging 40 dB. 
Two patients with a large conductive hearing loss underwent incus replacement 
procedures. In one 16-year-old patient who, as a child, had twice undergone 
mastoidectomy, the incus was luxated and the stapes was intact and mobile. A chain 
reconstruction took place using an allograft incus. The air-bone gap was reduced from 
40 to 20 dB. In a 36-year-old patient, an intact and mobile stapes was found as well as 
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Figure 4: Fotograph of Dr. Gerlings performing a fenestration of the semicircular 
canal in a patient (No. 40) suffering from osteogenesis imperfecta. 
At that time (1948) it was a new topic in surgery for otosclerosis, which 
was the reason for publication in the Utrechtse Courant. 
an incus with a thin and shortened process. A chain reconstruction took place using 
an autologous incus. The air-bone gap was reduced from 50 to 30 dB, but there was 
no improvement in hearing since there was a postoperative perception loss of 15 dB. 
Although patients with osteogenesis imperfecta have an increased risk of fracture of 
the base of the skull, there are no indications that this could have played a role in the 
conductive loss established in these two patients. 
DISCUSSION 
The results of stapes surgery in patients with osteogenesis imperfecta in the 
Netherlands are presented in such a way that they can be compared with the results 
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of two earlier American and Danish studies. · The present study does show an 
earlier onset of hearing loss. The average age at the onset of the hearing loss was 18.4 
years, while in the Danish study it was 23 years. The age at which stapes surgery took 
place, however, is the same. In this series it was 30.6 years, and in the Danish study it 
was 31 years. The data in the American study are too sketchy to allow comparisons to 
be made. This study states that the onset of hearing loss is especially seen in the 
second decade (42% of cases). 
The results of stapes surgery in osteogenesis imperfecta are compared in the present 
study with the American and Danish studies. Since each of these studies used a 
different post-operative investigation moment, 3 and 12 months, individual 
comparisons are more difficult (Table 1). 
In our study, after 3 months 85% of the operations had led to a hearing gain of more 
than 10 dB. The Danish study by Pedersen24 achieved a 100% success rate, although 
this included those patients with a hearing gain of less than 10 dB. The details of the 
hearing thresholds in the Danish study, which agreed with Figures 1 through 3 in our 
study, showed that four to six of these ears had a hearing gain of less than 10 dB. This 
reduces the 100% score in the Danish study to 86% or 91%. In the present study, 
there was a hearing gain of more than 10 dB in 81% of 46 operated ears after 12 
months. The results in the American study are almost the same, 84% in 51 ears. 
An inventory was also made of the presence and size of a direct postoperative air-
bone gap (Table 2). In the present study, 37 (71%) of 52 ears had a closed air-bone 
gap after 3 months; in the Danish study, this was found in 26 (62%) of 42 ears. After 
12 months, 31 (78%) of 40 ears in our study had a closed air-bone gap; in the 
American study, the results were 38 (75%) of 51 ears. 
The results of stapes surgery after 3 and 12 months are more or less the same in the 
present, Danish, and American studies. Tables 4 and 5 present the average hearing 
gain and the air-bone gap, as far as these data were available, alongside each other. 
This shows that there is a long-term reduction of approximately 8 dB in hearing gain, 
just as found by Pedersen and Elbr0nd,21 and that the air-bone gap remains more or 
less the same. 
Our series and the Danish series present the collected results of a large number of 
ear, nose, and throat surgeons, unlike the American series, which comes from one 
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center. In this respect, the results herein compare favorably with the other two 
studies. The number of operated ears with a follow-up of more than two years is 
almost the same in our study as in the American and Danish studies together. All 
three studies have patients with extremely long follow-up periods of 17, 18, and 24 
years. A hearing gain of more than 10 dB above the preoperative hearing threshold in 
the follow-up period is present in 27 (68%) of 40 ears in the our study (Table 3). 
Shea and Postma20 found a comparable hearing gain in 18 (75%) of 24 ears; Peder-
sen24 found this in 17 (77%) out of 22 ears. The air-bone gap in the three studies 
after 3 and 12 months showed little difference, but long-term individual comparison of 
these data is not really possible. In our study, there was a completely, or almost 
completely closed air-bone gap in 26 (70%) of 37 ears; while this percentage was 71% 
and 78% after 3 and 12 months, respectively (Tables 2 and 3). Pedersen2"1 reported 
this in his figures for 5 (23%) of 22 ears. Shea and Postma20 did not report the air-
bone gap in the follow-up period. 
It is as important to analyze further the disappointing results of stapes surgery in 
osteogenesis imperfecta as it is to analyze short-term and long-term successes. Despite 
the fact that the data regarding these operations had to be collected from many 
different sources, it is clear in assessing the increase in the perception loss that two 
separate possibilities may be involved. The first possibility is that the hearing loss 
increases in direct relationship to the operation and that there is a causal connection. 
This is true for 6 (10%) of 58 ears in our series without this event having led to 
complete perception loss in those ears. Second, it is possible that the long-term 
increase in perceptive hearing loss results principally from the natural course of the 
disease, ' especially since the same progression is often seen in the other, 
nonoperated on ear of the same patient. These disappointing long- term results need 
not necessarily be caused by the stapes surgery performed. 
The results of the American series from one center20 differ very little from the current 
study and the Danish study, each of which reviewed data gathered from many places 
in these countries. The rarity of this disease and the occasionally remarkeable surgical 
findings, together with the sometimes severe long-term and short-term progression of 
the perceptive hearing loss, support our contention that such surgery should take 
place in centers specialized in ear surgery. 
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Our conclusion is that the long-term and short-term results of stapes surgery in 
osteogenesis imperfecta are sufficiently encouraging to justify continuing with this 
form of treatment. 
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STAPES SURGERY IN OSTEOGENESIS IMPERFECTA. 
ANALYSIS OF POSTOPERATIVE HEARING LOSS. 
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ABSTRACT 
The disappointing results in 12 of 58 stapedectomies, including four revision 
operations, performed on osteogenesis imperfecta patients were analyzed and 
compared with reports in the literature. 
It is concluded that the results described as disappointing were not always the product 
of the stapes operation. A progressive senson-neural hearing loss arising 
independently of the operation as a result of progression in the disease process of 
osteogenesis imperfecta appears to have a severe influence on the final hearing 
threshold. 
INTRODUCTION 
Osteogenesis imperfecta is characterized by bnttleness of the bones, blue sclerae, and 
progressive hearing loss. The hearing loss usually begins in the second or third decade. 
It can be a pure conductive or a mixed loss. Pure perception losses, especially of the 
higher frequencies, are common1 The conductive component in the hearing loss is 
usually the result of fixation of the stapes footplate, as in otosclerosis, sometimes 
there is a stapes fracture. Until the 1970s, the middle ear changes in osteogenesis 
imperfecta were considered to be a severe form of otosclerosis 2 A Stapes surgery in 
osteogenesis imperfecta was therefore considered to be risky5 On histological, 
biochemical, and clinical genetic grounds, it must be recognized that otosclerosis and 
osteogenesis imperfecta are not only recogmsably different disease entities,616 but also 
that osteogenesis imperfecta represents a group of various different disease processes 
that sometimes have very similar clinical manifestations 17 20 
To improve the hearing loss, fenestration of the lateral semicircular canal was 
performed in the 1940s and 1950s,22125 followed later by stapes mobilisation232526. 
These operations had little success. The first successful report of stapedectomy in 
osteogenesis imperfecta appeared m I96023 More publications followed later, usually 
covering a small number of operations with variable success.5 ^ 2 7 37 It was not until 
the 1980s that a few series were published that reported on ear operations in more 
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than 10 patients. The results were usually good. 
The operative findings and the short-term and long-term results of stapes surgery are 
reported, especially in the three largest studies.39,40·'12 
This article presents an analysis of the disappointing results among the 58 ears in the 
Dutch series of stapes operations for osteogenesis imperfecta. A review of the 
relevant literature is also given. 
PATIENTS AND METHODS 
We studied hearing loss in sufferers of osteogenesis imperfecta by collecting data on 
stapes surgery in this disease. We combined data from the Nijmegen series37,41 with 
those from other Dutch otologic surgeons. Some of these cases were reported 
spontaneously by these otologic surgeons following an appeal for such cases, while 
others were traced through a study of hearing loss in Dutch patients with osteogenesis 
imperfecta. The Dutch Association of Patients with Osteogenesis Imperfecta also lent 
its active support. A retrospective study of the operation reports was therefore made, 
and where possible, all audiological data were traced. At the same time, an attempt 
was made to extend the follow-up period by performing new pure tone audiometry 
studies. Other, non-otological data such as the number of fractures were also 
collected.42 This Dutch series contained 58 stapedectomies in 47 patients with 
osteogenesis imperfecta. They were operated on during the period from 1960 to 1988 
for fixation of the stapes. In 4 of the 58 ears, a revision operation was also performed. 
In 12 of the 58 stapes operations, the ultimate results proved disappointing, either 
directly after the operation and within a period of 12 months, or after more than 12 
months. These operations were in 10 patients - 3 men and 7 women ranging in age 
from 15 to 45 years - who underwent stapes surgery between 1963 and 1988. 
In order to be considered as disappointing, a result had to meet the following criteria: 
1. Directly after the operation: an increase in the hearing loss, failure to achieve a 
hearing gain of more than 10 dB Fletcher-index (mean hearing loss at 0.5, 1, 
and 2 kHz), or an increase of the bone conduction threshold of 10 dB 
Fletcher-index or more despite an improvement in the air conduction threshold 
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of more than 10 dB Fletcher-index. 
2. After 12 months post-operatively: an increase in the air conduction threshold 
of more than 20 dB Fletcher-index, or an increase of the bone conduction 
threshold of an average of 15 dB or more Fletcher-index. 
We looked for common factors in these disappointing results (presumed failures) as 
compared with the successful operations. Features such as age at onset of hearing 
loss, the age at which the first stapes operation took place, the number of fractures, 
the sex of the patient, the technique of stapes surgery, the perioperative findings, and 
the preoperative bone conduction thresholds, from our complete group of 58 ears and 
from comparable studies5·25,29'35,38'40 were compared retrospectively in order to see if 
there are indicators of a reduced chance of a successful operation. 
RESULTS 
Data could be gathered from 47 patients who had undergone operations in the 
Netherlands for stapes fixation during the period from 1960 to 1988. There were 17 
men and 30 women; the sex ratio was therefore 1 to 1.8. 
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Table 1 also presents the sex ratio for the patient groups of an American study, a 
Danish study,40 and a combination of 10 studies compiled by us.5,25,29"35,38 The data 
from the 12 of 58 ears in which the results could be described as disappointing are 
listed separately (presumed failures). 
Of 174 out of 178 patients who underwent ear operations, there are 119 women 
(68%) and 55 men (32%). Table 2 notes the number of fractures for our patients as 
well as for those of other series. The age (by decade) at which the first stapes 
operation was performed is stated for each patient in Table 3. The ages in the Dutch 
series range from 10 to 63 years, with an average of 30.6 years. For the 12 ears in 
which results were considered disappointing, the age at operation was even lower. For 
the 6 of these 12 ears in which there was an increase in hearing loss directly after the 
operation, the average age at stapes surgery was 20.0 years, as opposed to 36.3 years 
for the 6 ears with hearing loss that occured later. 
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Note: Dash - indicates not applicable for lack of data. 
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Table 3: Age at time of first stapes operation 
AgeCyrs) 
0 - 9 
1 0 - 1 9 
2 0 - 2 9 
3 0 - 3 9 
4 0 - 4 9 
5 0 - 5 9 




S h e a * 
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Note: Dash - indicates not applicable for lack of data. 
• Data unknown for 27 patients. 
Table 4: Age at onset of hearing loss 
Age(yR) 
0 - 9 
1 0 - 1 9 
2 0 - 2 9 
3 0 - 3 9 
4 0 - 4 9 
50 or more 
Unknown 
Total 
S h e a * 


























































































































Table 4 and Table 5 show that 26 of the 43 patients (60%) already had hearing loss 
before 20 years of age and that the average age at onset was 18.4 years. In the group 
with disappointing results, this was the case in 8 of 10 patients (80%), with an average 
age at onset of hearing loss of 16.6 years. On average, the age at onset of hearing loss 
in the Danish, American, and combined groups ("Others") was several years later. 
Table 5: Mean age at onset of hearing loss 
No of patients 
Unknown 






































Dash - not applicable for lack of dala. 
Table 6: Methods of stapes surgery 


































































































































Dash - not applicable for lack of data. 
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Dash - not applicable for lack of data. 
The various techniques for performing stapes surgery, as well as those for total 
stapedectomy, partial platinectomy, stapedotomy, and partial stapedectomy are listed 
in Table 6 and Table 7. In 31 of 58 ears (53%) a total stapedectomy was performed, 
but after 1980, partial platinectomy and stapedotomy were more frequently 
performed. Before 1980, only 4 of 27 ears (15%) were treated by partial platinectomy 
or stapedotomy; after 1980, 22 of 31 ears were (78%). 
The operative findings in the stapes footplate, the stapes crura, and the middle ear 
mucosa in the region of the oval window are listed in Table 8. A moderate-to-severe 
thickening of the footplate was found in 32 of 58 ears (55%). In all the studies 
together, this was found in 134 out of 234 ears (57%). In the group with disappointing 
results, the footplate was thickened in 10 of the 12 ears (83%). Further 
differentiationshowed that the majority of the thickened footplates was solidly 
thickened - a finding sometimes observed in the form of an obliteration of the oval 
window. In the present study, this finding was seen in 22 of the 32 thickened 
footplates (69%). In the group with disappointing results and in the study of Shea and 
Postma,39 all thickening of the footplate was solid. In 15 of 58 ears (26%) in the 
present study a soft or friable footplate consistency was reported, and in all the 
studies together, this was found in 61 out of 234 ears (26%). The group with 
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Table 8: Findings during stapes operation 














































































































































































































































disappointing results shows no differences here. Thickened edges and/or bony 
apposition anteriorly and posteriorly on the footplate, which hinders a good approach, 
were seen in 11 of the 58 ears (19%). In all studies together this was seen in 25 out of 
234 ears (11%). In the group with disappointing results, it was found in 4 of 12 ears 
(33%). A remarkable number of reports in the present study state that even the 
footplate itself bled easily during the operation (8 of 58 ears or 14%). In all studies 
together this was reported in 9 of 234 ears (4%), and in the group with disappointing 
results, in 3 of 12 ears (25%). The presence of a floating footplate is sometimes 
correlated to a thick and soft footplate. If it should be necessary to remove the stapes 
superstructure early, without being able to introduce a safety hole into the footplate, 
the chance of a floating footplate will clearly be increased, partly because of the 
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reduced fixation. This occurence was seen in 2 of the 12 ears (17%) with 
disappointing results. In all studies together, a floating footplate occurred in 5 of 234 
ears (2%), with a resultant increase in sensorineural hearing loss.30,32'12 
In 11 of 58 ears (19%), detailed information about the configuration of the stapes 
crura was not available. Normal crura were found in 112 out of 234 ears (48%), 
although there was some variation among the individual studies. In 10 of 58 ears 
(17%) the crura appeared to be interrupted. This finding was reported in 29 of the 
234 ears (12%), with an individual variation of 0% to 20%. The crura were thin 
and/or atrophic in 22 of the 58 ears (38%). A total of 67 of the 234 ears (29%) had 
similar crura. In the group with disappointing results, thin and/or atrophic crura were 
found in 5 of 12 ears (42%), and there were no fractures. 
A thickened mucosa was seen in 7 of the 58 ears (12%) and in 22 of the 234 ears 
(9%), with individual variations of between 0% and 28%. In the group with 
disappointing results, however, a thickened mucosa was found in 5 of the 12 ears 
(42%). It is also remarkable that in 12 of the 58 ears (21%) it was stressed that the 
mucosa bled readily, while in 19 ears (33%), there is no report of this; and the 
mucosa was described as normal in 24 of the 58 ears (41%). In all studies together, a 
remarkably haemorrhagic mucosa was reported in 49 of the 234 ears (21%). This 
abnormality, too, occurs more frequently in the group with disappointing results (5 of 
12 ears or 42%). 
In total, we established that for 12 of these 58 stapes operations (21%), the results 
directly after the operation or after a period of more than 12 months were 
disappointing according to our standards. The preoperative and postoperative hearing 
levels of these 12 ears in 10 patients are presented in Figs 1 through 7, together with 
the simultaneously recorded hearing levels in the 8 contralateral ears. 
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un operated ears 
Figure 1: (Patient 1) Follow-up results in terms of average pure tone thresholds 


















































Figure 2: (Patients 2 and 3) Follow-up results in terms of average pure tone 
thresholds (decibels hearing level) for frequencies 0.5, 1, and 2 KHz. 
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Patient 4 
Surgery yes revision 
19Θ7 1988 
Follow-up 



























Figure 3: (Patients 4 and 5) Follow-up results in terms of average pure tone 





















Figure 4: (Patients 6 and 7) Follow-up results in terms of average pure tone 















1 Air-bone gap operaled ears jf I pre - and postoperative 
Air conduction 
1
 threshold with 
1 unknown bone 
Τ conduction threshold 
Air-bone gap 
unoperated ears 
Figure 5: (Patient 8) Follow-up results in terms of average pure tone thresholds 









































Figure 6: (Patient 9) Follow-up results in terms of average pure tone thresholds 
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Figure 7: (Patient 10) Follow-up results in terms of average pure tone thresholds 
(decibels hearing level) for frequencies 0.5, 1, and 2 KHz. 
Table 9 reports the ear, sex and age of each of these 12 patients, as well as the 
findings during operation, the type of piston used, the complications noted during 
operation as documented in the surgical report, and some other special findings. An 
increase in hearing loss compared with the preoperative hearing threshold was noted 
directly after the operation in 5 of the 12 ears (42%) (Figs 1 through 3; patients 1 
right, 2, 3, 4, and 5). The hearing threshold was unchanged directly after the operation 
in 1 of the 12 ears (8%) (Fig 1; patient 1 left). An acceptable-to-good hearing gain 
was achieved in 5 of the 12 ears (42%) (Figs 4 through 6; patients 6 both, 7, 8, and 
9). One of the 12 ears (8%) has been included in the totals although data are not 
available that could demonstrate any relationship between the operation and the 
hearing result (Fig 7; patient 10). It is remarkable that despite the findings and the 
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Table 9a: Findings at 12 stapedectomies in 10 patients with disappointing results. 
Immediate hearing loss. 
Pt Sex Ear 
1 F R 
2 F L 
3 F I 
4 M R 









































































































Note: HL = Hearing level; ? = unknown, ND = not delectable 
Table 9b: Findings at 12 stapedectomies in 10 patients with disappointing results. 
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Note: HL = Hearing level; ? = unknown, ND = not detectable 
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events (Table 9), no single ear became completely deaf after operation, although 3 of 
the 12 ears (patients 1 left and 6 both) developed a hearing loss of more than 90 dB 
at a later stage. In the other studies5,25,29"35·38^0 complete deafness arose in 5 of 176 
ears (3%) (Table ю29·30·32·39; patients 11 through 15). In 1 of the 5 ears (patient 12) 
the deafness arose only after three years, as apposed to the other 4 ears, in which a 
direct relationship with the operation could be established. In order to investigate if 
the size of the sensorineural component of the preoperative hearing loss could 
influence the chances of an unfavourable postoperative result, we collated the 
preoperative bone conduction thresholds and their averages from the various studies 
(Table 11). It is remarkable that in the present study, in the group with disappointing 
results, and in the study of Shea and Postma39 the several sensorineural hearing 
thresholds are equally divided. In the study of Pedersen and Elbr0nd40 and the 
combined studies5,25,29'35,38 it is principally the lowest perception thresholds that are 
present in the largest percentage. The averages of the preoperative bone conduction 
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Dash - not applicable for lack of data. 
•Extrapolaiion from figures. 
thresholds are clearly higher in the present study than in the other studies. 
In the present study revision operations were performed in a total of 4 out of 58 ears 
(7%). In two, the long process of the incus proved to be eroded, in one case there 
were also remnants of a chronic otitis media, and in one, the revision was performed 
following considerable external trauma. Only in one case did the revision result in a 
slight improvement in hearing (Fig 3; patient 4). In the other three, a hearing loss 
resulted, most probably completely sensorineural in nature (Figs 1, 5, and 6; patient 1 
left, 8, and 9). 
In the other studies, revision took place in 15 of 176 ears (9%). The findings in 5 of 
these 15 revisions are known (Table 1225·29·34; patients 16 through 19). From the total 
of 9 revisions described, adhesions and granuloma formation were present in 3 of 
them. In one ear, the oval window was obliterated. In 3 ears, the incus was eroded 
and in one case the strut was too short - a finding that could also indicate erosion. In 
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Patterson and Stone2 9 
Pattercon and Stone2 9 
Cohen3 4 
Findings at revision 
Polyethylene strut too short, replaced by longer one; (loating 
footplate; fat mass under longer stmt 
Incus marked with multiple granulomata; granulomatous mass 
extended from under incus to fill oval window niche 
Oval window closed with iceberg-type bone 
First revision: Teflon cup piston not found, no fistula; distal 
pan of incus disappeared; TORP between incus and oval 
window membrane 
Second revision: granuloma between shaft of TORP and nm of 





18 dB hearing 
level 
SO dB air-bone gap 
20 dB air-bone gap 
one case trauma had loosened the piston. 
Of the 19 revisions from all the studies, only 6 (32%) showed an adequate-to-good 
result or closure of the air-bone gap. In 5 ears there was deterioration of hearing and 
in one case it was unchanged. The data for 3 ears are unavailable. In 4 ears, deafness 
resulted that was as good as total. 
DISCUSSION 
It is probable that the clinical presentation and also the nature of the hearing loss in 
osteogenesis imperfecta are the same as in otosclerosis. The distribution with regard 
to sex shows a female predominance of at least 2 to 1 in the 174 operated cases of 
osteogenesis imperfecta. The figures known from operated cases of otosclerosis 
patients are almost exactly the same.8'43,44 The onset of hearing loss before the 20th 
year was established in a total of 64 of 129 patients (50%) (Table 4), without a 
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descriptive definition of this level of hearing loss being given. Otosclerosis also 
presents at a very young age, but less frequently so than osteogenesis imperfecta. 
Robinson45 found an onset of hearing loss before the age of 18 years in 610 of 4014 
otosclerosis patients (15%). In our group with disappointing results, 8 of the 10 
patients (80%) were hard of hearing before 20 years of age. The question arises as to 
whether patients with an increased risk can be recognized in advance. First of all, it 
appears that these patients already have considerable loss of hearing at an early age 
(Tables 4 and 5), and, generally, they come to operation at a younger age (4.5 years 
younger) than average (Table 3). In the group with an increase in hearing loss directly 
after the operation, the average age at stapes surgery is even as low as 20.0 years, as 
opposed to 36.3 years in the group with hearing loss in the long term. Furthermore, 
the at-risk patient has a solidly thickened footplate (83%) with thickened edges (33%) 
and haemorrhage (25%) (Table 8). The crura are thin and atrophic (42%). The 
mucosa of the middle ear is thicker than normal (42%) and also leads to troublesome 
haemorrhage (42%). It also appears that the at-risk patient has a higher preoperative 
bone conduction threshold (Table 11). On the other hand, the at-risk patient shows 
no differences with regard to sex (Table 1), the number of fractures (Table 2), or the 
materials used during stapes operation (Table 6). However, a total stapedectomy had 
usually been performed in the group with disappointing results (Table 7). 
The findings and events during operation could be reasons for the ultimately poor 
result. In the group with an increase in the hearing loss directly after the operation, a 
solidly thickened footplate, large bony appositions, and an oval window that was 
difficult to access had a detrimental influence on the operative results in five of six 
ears. In the group with an increase in the sensorineural component of the hearing loss 
12 months after the operation or later, no causal relationship with the disease or with 
the middle ear could be established in three of six ears. In the three other ears from 
this group in which a severe sensorineural hearing loss arose later on, the disease 
process itself proved to be the cause. 
When there is a continuous progression of the sensorineural hearing loss as a result of 
the bone disease itself, there is a good chance that this will be bilateral. In nearly 
every nonoperated contralateral ear, an increase in the sensorineural component of 
the hearing loss could be established if the follow-up period was long enough. In the 
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group of 6 ears with an increase in hearing loss directly after the operation, a 
progression of the sensorineural hearing loss still occured in the follow-up period after 
the surgical accident. 
Considering these data it can be concluded that stapes surgery in osteogenesis 
imperfecta has more pitfalls than in otosclerosis. The disease process itself leads to 
changes in the form and structure of the footplate, the stapes superstructure, and the 
other components of the ossicular chain, so that no two ears show exactly the same 
picture. That is why more complications are encountered than in the otosclerosis 
operation. It is remarkable that despite the increased number of complications, there 
were no deaf ears directly after the operation in this Dutch series of 58 ears, as 
opposed to other studies29,30·32,39. Revision operations proved to be risky, since in only 
6 of 19 ears (32%) was a good result achieved. 
A notable finding in this study was that a progressive sensorineural hearing loss that is 
not related to the operation can have an important if not decisive effect on the 
ultimate result. Not infrequently, an apparently good operative result can be destroyed 
in the short, but usually longer, term by a severe sensorineural hearing loss. It is 
unjustified to consider these operations as failures. Frequent postoperative 
measurement of the bone and air conduction thresholds, even after a good result, is 
necessary to answer possible questions about hearing loss of later onset. A reliable 
prediction of the ultimate hearing threshold in the long term is difficult to make 
because of the progressive inner ear deafness that is associated with the disease 
process. It is remarkable that the group with disappointing results directly after the 
operation was relatively young and had a high preoperative bone conduction 
threshold. All these patients proved to have complication-sensitive changes in the 
footplate and oval window. It is precisely this risk group that needs the highest care 
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SUMMARY AND CONCLUSIONS 
INTRODUCTION 
One of the original aims of this study was to gain more insight into the progression 
and nature of the hearing loss in patients with osteogenesis imperfecta. During the 
course of the study, this aspect had to be limited to osteogenesis imperfecta type I. 
Sufficient data could be collected on osteogenesis imperfecta type I in fully 
investigated families to discover and describe the negative influence of selection of the 
study data. 
Nevertheless during the study period, the availability of sufficient unpublished data on 
other non-lethal forms of osteogenesis imperfecta enabled us to conclude that hearing 
loss is also associated with type III and type IV. It is also possible that the frequency 
of hearing loss in type III is higher and even more severe than that found in type I. 
We therefore propose that this research be continued to investigate other types of 
osteogenesis imperfecta. 
CLINICAL GENETIC RESEARCH 
The segregation of the symptoms and the penetrance of the characteristics were 
analysed in 30 fully investigated family pedigrees with 144 random members. The 
calculated segregation analysis, or the ratio between the actual number of patients 
and the number of patients calculated on the basis of an autosomal dominant mode of 
inheritance was 70:72, i.e. 97%, which closely approaches the ideal score of 100% for 
an autosomal dominant syndrome. 
The incidence of the separate characteristics, such as blue sclerae and bone fractures, 
were no different from those reported in the literature, namely 100% for blue sclerae 
and 87% for fractures. The average incidence of hearing loss was 43% and the 
percentages grew larger with increasing age and appeared to be age-related. It is 
striking that the average percentage of sufferers with hearing loss in various family 
studies is in agreement with the percentage found in our 144 subjects. We therefore 
consider the data from these studies to be correct and we assume that the other non-
family studies and the study described in Chapter 3, were hindered by negative 
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selection. On the basis of these studies, we can conclude that the incidence of hearing 
loss in osteogenesis imperfecta type I is 43%. In addition, calculation of the 
penetrance in successive generations showed that there is a clear relationship between 
age and the progression of the hearing loss, which is illustrated in a plot diagram 
(Chapter 2; Figure 2). There were very few elderly patients with normal hearing. 
Dividing the family members into two groups with or without male-to-male 
inheritance did not produce any evidence of a genetically distinguishable type with an 
X dominant mode of inheritance, such as in the Alport syndrome. 
HEARING LOSS AND AGE 
The audiometrie data from 142 sufferers were further analysed and for the sake of 
recognizing any selection bias, they were compared to those from a random sample of 
the same population. The extremely high incidence of hearing loss of 78% in the 142 
sufferers is the result of considerable selection on an age of younger than 30 years. An 
analysis of the difference between the two groups showed that the patients were 
between 10 and 30 years of age with an average hearing loss of 30-50 dB, which 
exceeds the lower limit for social hearing. 
The following conclusions could be drawn from the data after they had been corrected 
for the above-mentioned negative selection: the average hearing loss increased 
between the 10th and 45th year by 1 dB per year for the frequencies 0.5 to 2 kHz, by 
1.1 dB per year for 4 kHz and by 1.7 dB per year for 8 kHz. The conductive 
component for all the frequencies remained constant at 0.4 dB over the total period. 
For patients in the post-operative phase after stapes surgery, a decrease in the 
hearing level of about 0.8 dB per year can be expected (Chapter 5). This hearing loss 
was almost completely perceptive, also on account of the difference between the bone 
and air conduction thresholds in the follow-up period. 
Our present data show progression of the hearing loss (both conductive and 
perceptive) with increasing age and for the first time it has become possible to further 
describe this progression between the age of 10 and 45 years. The data also show a 
clear distribution of the severity of the hearing loss, even in the same age groups. The 
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conductive loss does not always deteriorate to such an extent that it forms a general 
indication for stapes surgery. Nevertheless the risk that a person suffering from 
osteogenesis imperfecta type I will be confronted by considerable hearing loss during 
adult life as a result of the disease, is in our opinion fairly high. Consequently, the 
onset of hearing loss besides other hindering factors which might result from the 
syndrome, such as bone fractures, is a factor for the patient to keep in mind when 
choosing an occupation. This auditory handicap will become most troublesome in the 
communicatively-geared occupations where people have to understand speech while 
there is a great deal of background noise. If the patient is suffering from considerable 
inner ear hearing loss, rehabilitation with a hearing aid will not be adequate for 
hearing speech under difficult (noisy) circumstances. Long-term avoidance of these 
more difficult hearing conditions, particularly noisy circumstances, will not always be 
possible at a more advanced age in every profession. The possibility of retraining also 
has its limitations. In our opinion therefore, it would be correct to take our present, 
although limited knowledge of the risk of progressive hearing loss in persons suffering 
from osteogenesis imperfecta type I into consideration when choosing a career or 
occupational training. 
STAPES SURGERY 
Although it was not explicitly mentioned that the patients described in Chapters 4, 5 
and 6 and in the two large series in the literature were suffering from osteogenesis 
imperfecta type I, it is probably true of the majority of them, if not all. In isolated 
cases of osteogenesis imperfecta with hearing loss at a young age and serious 
symptoms resulting from many factors, it is very easy to be hesitant, especially in 
retrospective studies. It is for this reason that the authors preferred not to speak 
explicitly about osteogenesis imperfecta type I. 
It is striking that contrary to similar operations for otosclerosis, broken and atrophic 
stapes crura are often found. In addition, troublesome bleeding of the footplate or of 
the mucosa is also seen more often. Many of the fixed stapes footplates were found to 
be thickened and brittle. Such findings which deviate from otosclerosis can have a 
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negative influence on the surgical results. 
The results of stapes surgery for osteogenesis imperfecta (type I) at the Nijmegen 
Ear, Nose and Throat Clinic (Chapter 4) and in a large Dutch series (Chapter 5) can 
be classified as good. In comparison with two other large foreign series, they more 
than adequately bear the test of criticism. 
In the long-term, it appears that there is a hearing loss of 0.8 dB per year. The 
average air-bone gap (air-bone conduction component) in the post-operative period 
hardly changed for the frequencies 0.5, 1 and 2 kHz: 9.6 dB to 11.7 dB, or 0.2 dB per 
year. Therefore, a large proportion (0.6 dB) of the average annual decrease in the 
post-operative hearing gain is the result of progression of the perceptive hearing loss. 
The cause most probably lies in the natural course of the disease. In Chapter 3, it was 
found that in a large group of 142 sufferers who had not been operated on, the 
average annual progression of the hearing loss was 1 dB for the frequencies 0.5, 1 and 
2 kHz between the age of 10 and 45 years (0.6 dB perceptive loss and 0.4 dB 
conductive loss). Despite the fact that operated patients with considerable mixed 
hearing loss underwent stapes surgery at a relatively young age, the course of the 
post-operative hearing loss ran almost parallel with the natural course. 
In 12 out of the 58 stapes operations in the Netherlands, we consider the initial short-
term and long-term results to be disappointing (Chapter 6). In one group of six 
operations, no hearing gain was achieved or the hearing deteriorated in the post-
operative phase, which seems to be clearly linked with the intervention. In the second 
group of six operations, hearing loss developed in the long-term, after what had 
appeared to be a good post-operative result. The incidence of complications was 
higher in the former group, which indicates a surgical cause for the poor results; there 
were also more abnormalities susceptible to complications in the middle ear. It was 
striking that in both groups, but particularly in the group with disappointing long-term 
results, the progressive, perceptive hearing loss, which is an expression of the disease 
itself, was manifested bilaterally. What at first appeared to be a good post-operative 
result can, in the course of time, change into severe hearing loss, particularly if the 
follow-up period is long enough, which can be observed in the symmetrical progressive 
occurrence of inner ear hearing loss in sufferers who were only operated on 
unilaterally. 
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We have found that the members of both groups, i.e. those with surgical 
complications and those with late onset progressive perceptive hearing loss, could 
have been recognised to some extent pre-operatively. There are several common 
characteristics. Firstly, they all suffered from considerable hearing loss at a young age 
and underwent stapes surgery at a young age. Secondly, they had a solid, thickened 
footplate with upturned edges which was very susceptible to bleeding. The stapes 
crura were thin and atrophic and the middle ear mucosa was thicker than normal and 
also susceptible to bleeding. Tests also showed that the pre-operative bone conduction 
threshold was higher than average. 
In conclusion, stapes surgery for osteogenesis imperfecta is associated with more 
pitfalls than otosclerosis, which is clinically similar. Changes occur in the middle ear as 
a result of the disease itself, which give rise to a higher risk of complications and 
increase the risk of a disappointing result. In addition, the disease can generate a 
symmetrical, progressive perceptive hearing loss, which can completely destroy a good 
post-operative result within a few years. Nevertheless it is unjust to consider these 
operations a failure. The increase in inner ear hearing loss in the long-term following 
surgery is not the result of the intervention, but the result of the progression of the 
disease with increasing damage to the inner ear. Whether or not stapes surgery forms 
a worthwhile alternative to rehabilitation with a hearing aid should be carefully 
weighed up in each individual case. In view of the high risk of complications during 
stapes surgery for persons suffering from osteogenesis imperfecta, it is recommended 
to leave this operation to the most experienced otologist. 
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SAMENVATTING EN CONCLUSIES 
INLEIDING 
Eén van de oorspronkelijke doelstellingen van dit onderzoek was inzicht te krijgen in 
de progressie en de aard van het gehoorverlies bij osteogenesis imperfecta. In de loop 
van het onderzoek moest dit deel van deze studie beperkt worden tot osteogenesis 
imperfecta type I. Van dit type konden voldoende gegevens uit volledig onderzochte 
families worden verkregen om de negatieve invloed van een selectie in de 
onderzoeksgegevens te kunnen achterhalen en omschrijven. 
Toch zijn tijdens dit onderzoek ook voor andere niet-lethale vormen van osteogenesis 
imperfecta voldoende ongepubliceerde audiologische gegevens verworven om te 
kunnen melden dat gehoorverlies niet alleen bij type I, maar ook bij type III en type 
IV voorkomt. Mogelijk komt het gehoorverlies bij het type III vaker en zelfs in een 
ernstigere mate voor, dan wij nu weten van type I. Het voortzetten van dit onderzoek 
voor deze andere typen van osteogenesis imperfecta wordt daarom hier bepleit. 
KLINISCH GENETISCH ONDERZOEK 
De segregatie van het ziektebeeld en de penetrantie van de kenmerken werden van 
30 volledig onderzochte familiestambomen met 144 aselecte nakomelingen 
geanalyseerd. De berekende segregatie-analyse, ofwel de ratio tussen het werkelijk 
gevonden aantal patiënten en het op basis van een autosomaal-dominante overerving 
berekende aantal patiënten, bedroeg 70:72 ofwel 97%, de ideale score van 100% voor 
een autosomaal-dominant ziektebeeld benaderend. 
De frequentiepercentages van de afzonderlijke kenmerken, zoals blauwe sclerae en 
botbreuken, wijken niet af van wat in de literatuur verondersteld werd, namelijk 100% 
voor blauwe sclerae en 87% voor fracturen. Voor het gehoorverlies wordt een 
gemiddeld frequentiepercentage gevonden van 43%, welke voor de opeenvolgende 
decaden afzonderlijk meer verschilt en leeftijdsgebonden blijkt te zijn. Het is 
opvallend dat het gemiddelde percentage lijders met een gehoorverlies bij diverse 
familiestudies overeenkomt met de alhier beschreven groep van 144 nakomelingen. 
De cijfers uit deze familiestudies achten wij daarom ook de juiste en wij nemen 
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derhalve aan dat de andere niet-familie studies, evenals onze studie vermeld in 
Hoofdstuk 3, gehinderd worden door een negatieve selectie. Het lijkt daarom 
verantwoord er voortaan vanuit te gaan dat de incidentje van het gehoorverlies bij 
osteogenesis imperfecta type I 43% bedraagt. Verder blijkt, na berekening van de 
penetrantie bij opeenvolgende generaties, dat er voor gehoorverlies een zeer 
duidelijke relatie bestaat tussen de leeftijd en de progressie van het gehoorverlies, wat 
geïllustreerd wordt in een piotdiagram (Hoofdstuk 2: figuur 2). Op oudere leeftijd 
blijken er nog maar weinig patiënten te zijn met een normaal gehoor. De splitsing van 
de nakomelingen in twee groepen met of zonder een man-op-man-overerving heeft 
geen aanwijzingen verschaft, dat er een genetisch te onderscheiden type bestaat met 
een X-dominante overerving zoals bij het syndroom van Alport. 
GEHOORVERLIES EN LEEFTIJD 
De audiometrische gegevens van 142 lijders werden nader geanalyseerd, en omwille 
van het onderkennen van enigerlei selectie, vergeleken met een daaruit verkregen 
aselecte populatie. Het extreem hoge percentage gehoorverlies van 78% bij de 142 
lijders is een gevolg van een aanzienlijke selectie op een leeftijd jonger dan 30 jaar. 
Na analyse van het verschil tussen beide groepen blijkt dat het om patiënten gaat uit 
de leeftijdscategorie 10-30 jaren, met een gemiddeld niveau van gehoorverlies van 30-
50 dB, de grens van het sociaal horen overschrijdend. 
Wanneer onze onderzoeksgegevens gecorrigeerd worden voor de eerder beschreven 
negatieve selectie, kan als volgt geconcludeerd worden. Het gemiddelde gehoorverlies 
neemt tussen het 10e en 45e jaar met 1 dB per jaar toe voor de frequenties 0,5-2kHz, 
met 1,1 dB per jaar voor 4kHz, en met 1,7 dB per jaar voor 8kHz. Daarvan bedraagt 
de conductieve component voor alle frequenties constant 0,4 dB gedurende de gehele 
periode. Voor patiënten in de postoperatieve fase na stapeschirurgie bleek eerder 
reeds (Hoofdstuk 5) dat een afname van het gehoor van ongeveer 0,8 dB per jaar te 
verwachten is. Dit verlies blijkt vrijwel volledig van perceptieve aard, mede gezien het 
vrijwel constant blijven van het verschil tussen de been- en luchtgeleidingsdrempels in 
de follow-up periode. 
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De thans voorhanden zijnde gegevens tonen de progressie van het gehoorverlies, 
zowel van conductieve als van perceptieve aard, met de leeftijd. Voor het eerst is het 
gelukt deze progressie tussen het 10e en 45c jaar nader te omschrijven. De gegevens 
tonen tegelijk een duidelijke spreiding in ernst van het gehoorverlies, ook voor 
dezelfde leeftijdsklasse. Het geleidingsverlies wordt ook niet obligaat zo groot dat 
doorgaans een indicatie voor stapeschirurgie zal ontstaan. Toch is de kans dat een 
lijder aan osteogenesis imperfecta type I tijdens de volwassenheid met een fors 
gehoorverlies als gevolg van de ziekte geconfronteerd zal worden naar ons oordeel 
tamelijk groot. Wij menen daarom dat het optreden van gehoorverlies, naast andere 
belemmerende factoren die kunnen voortvloeien uit het ziektebeeld, waaronder 
fracturen, ook een factor is die de beroepskeuze zou mogen beïnvloeden. Vooral in 
de communicatief ingestelde beroepen waar men temidden van achtergrondsgeluiden 
de spraak steeds moet kunnen verstaan, zal deze auditieve handicap het eerst 
hinderlijk worden. Wanneer het om aanzienlijke binnenoorverliezen gaat zal voor 
moeilijke luisteromstandigheden revalidatie met een hoortoestel onvoldoende uitkomst 
bieden. Het duurzaam ontwijken van deze moeilijkere luisteromstandigheden, met 
name een geluidsrijke omgeving, zal op oudere leeftijd niet voor een ieder in elke 
professie mogelijk zijn. Mogelijkheden voor omscholing hebben ook hun beperking. 
Wij menen daarom dat het juist zou zijn om de huidige toch nog beperkte kennis over 
de kansen op een progressief gehoorverlies bij lijders aan osteogenesis imperfecta 
type I mede overwogen wordt bij het maken van een beroepskeuze of een keuze voor 
een beroepsopleiding. 
STAPESCHIRURGIE 
Alhoewel in de hoofdstukken 4, 5 en 6 over stapeschirurgie evenals in de 2 andere 
grote series in de literatuur niet expliciet vermeld wordt dat het bij deze lijders steeds 
om osteogenesis imperfecta type I gaat, geldt dit wel voor de meesten mogelijk zelfs 
voor hen allen. Bij een geïsoleerd voorkomen van osteogenesis imperfecta met ook al 
op jeugdige leeftijd een gehoorverlies en ernstige verschijnselen ten gevolge van vele 
factoren kan men zeker bij een retrospectieve studie op dit punt enige aarzeling 
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ervaren. Het is daarom dat de auteurs er de voorkeur aan hebben gegeven hier niet 
expliciet te spreken over osteogenesis imperfecta type I. 
Opvallend is dat in tegenstelling tot bevindingen bij vergelijkbare operaties voor 
otosclerose, er vaak gebroken en atrofische stapes crura worden gevonden. Ook een 
hinderlijke bloeding van de voetplaat of van de mucosa wordt meer gezien. Veel 
gefixeerde stapesvoetplaten blijken verdikt en broos te zijn. Deze van otosclerose 
afwijkende bevindingen kunnen het operatieresultaat in ongunstige zin beïnvloeden. 
De resultaten van stapeschirurgie bij osteogenesis imperfecta (type I) voor zowel de 
Nijmeegse Kliniek voor KNO-heelkunde (Hoofstuk 4) als die voor een grote 
Nederlandse serie (Hoofdstuk 5) zijn zonder meer als goed te beschouwen. In 
vergelijking met twee andere grote buitenlandse series, kunnen zij de toets der kritiek 
ruim doorstaan. 
Op lange termijn blijkt dat er een afname van de gehoorwinst van 0,8 dB per jaar op-
treedt. De gemiddelde air-bone gap (lucht-beengeleidingscomponent) in de 
postoperatieve periode voor de frequentie's 0.5, 1, en 2kHz verandert nauwelijks, 
namelijk van 9.6 dB naar 11.7 dB, ofwel 0,2 dB per jaar. Daarom zal een groot deel 
(0,6 dB) van de gemiddelde jaarlijkse afname van de postoperatieve gehoorwinst een 
gevolg moeten zijn van een progressie van het perceptieve gehoorverlies. De oorzaak 
hiervan lijkt het gevolg van het natuurlijke verloop van de ziekte. Reeds eerder was 
bij een grote groep van 142 niet-geopereerde lijders komen vast te staan, dat er een 
jaarlijkse progressie van het gehoorverlies optreedt van gemiddeld 1 dB over de 
frequentie's 0.5, 1, en 2kHz tussen het 10e en 45e jaar, waarvan 0,6 dB van 
perceptieve en 0,4 dB van conductieve aard (Hoofdstuk 3). Ondanks het feit dat 
geopereerde patiënten op relatief jonge leeftijd en met een aanzienlijk gemengd 
gehoorverlies stapeschirurgie ondergaan, blijkt dat bij hen het gehoorverlies 
postoperatief vrijwel gelijk op gaat met het natuurlijke verloop. 
Bij 12 van 58 stapes operaties in Nederland worden de resultaten door ons 
aanvankelijk op de korte of de lange termijn als teleurstellend beschouwd (Hoofdstuk 
6). Eén groep van 6 operaties kent een uitblijven van gehoorwinst of een 
gehoorverlies in de postoperatieve fase, zodat een relatie met de ingreep 
vanzelfsprekend lijkt. Daarentegen ontwikkelt bij een tweede groep van 6 operaties 
het gehoorverlies zich op lange termijn, na een in eerste instantie goed postoperatief 
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resultaat. In de eerste groep doen zich vaker complicaties voor, zodat een chirurgische 
oorzaak voor het slechte resultaat aanwijsbaar lijkt. In die groep blijken tevens meer 
complicatie gevoelige afwijkingen in het middenoor aanwezig te zijn. Opvallend voor 
beide groepen, maar met name voor de groep met het teleurstellende resultaat op 
lange termijn, is het feit dat een progressief perceptief gehoorverlies, een uiting van 
de ziekte zelf, zich bilateraal manifesteert. Een ogenschijnlijk goed postoperatief 
resultaat kan in de loop der jaren veranderen in een ernstige slechthorendheid, zeker 
indien de follow-up periode lang genoeg is, wat waar te nemen valt aan het 
symmetrisch progressief optreden van een binnenoorverlies ook bij slechts aan één 
oor geopereerde lijders. 
Voor beide groepen, zowel die met complicaties tijdens de operatie als die met het 
later intredende progressieve perceptieve gehoorverlies, blijkt dat zij ten dele 
preoperatief herkend kunnen worden. Er zijn enkele gemeenschappelijke 
eigenschappen. Allereerst blijkt dat zij reeds op jonge leeftijd een aanzienlijk 
gehoorverlies hebben, en al op jongere leeftijd stapes chirurgie hebben ondergaan. 
Daarnaast hebben zij een massief verdikte voetplaat met opgeworpen randen en een 
makkelijk optredende bloeding. De stapespootjes zijn dun en atrofisch, en de 
middenoormucosa is dikker dan normaal, wat een hinderlijke bloeding tot gevolg kan 
hebben. Ook blijkt dat de preoperatieve beengeleidingsdrempel veel ongunstiger is 
dan gemiddeld. 
Concluderend blijkt dat stapeschirurgie bij osteogenesis imperfecta meer valkuilen 
met zich meebrengt dan bij het klinisch vergelijkbare ziektebeeld otosclerose. Door de 
ziekte zelf ontstaan er veranderingen in het middenoor welke een verhoogde kans op 
complicaties geven en die de kans op een teleurstellend resultaat kunnen doen 
toenemen. Daarnaast kan de ziekte een symmetrisch optredend progressief perceptief 
gehoorverlies genereren, welke een postoperatief goed resultaat binnen een aantal 
jaren volledig kan laten verdwijnen. Het is echter onterecht om deze operaties als een 
mislukking te beschouwen. De na de operatie op langere termijn ingetreden toename 
van het binnenoorverlies is niet een gevolg van de operatie, maar van de progressie 
van de ziekte met een toenemende schade aan het binnenoor. De beoordeling of 
stapeschirurgie een verantwoord alternatief biedt ten opzichte van prothetisering met 
behulp van een hoorapparaat behoeft steeds een afweging in het individuele geval. 
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Gezien een verhoogde kans op complicaties bij stapeschirurgie bij lijders aan dit 








"When I was a child, my mother, who often invented pet names, used to call me 'my 
little saxe porcelain doll'. As young as I was, I did not connect any special meaning to 
it; I just thought it was nice. It was not until much later that I realized that it was a 
very apt description. I have no knowledge of ceramics; as far as 'saxe porcelain' is 
concerned, I can make vague associations with soul-stirring, pastoral, sculptured 
shepherdesses in sweet-voiced colours. But also with 'rare', 'vulnerable' and 'fragile'. 
And while I am writing this, with 'priceless', a meaning that my mother undoubtedly 
also intended. 
Anything that is vulnerable and delicate is generally treated with care and prudence. 
And that is now the very crux of the matter, what it is all about for we unfortunate 
souls suffering from such a treacherous condition, with an oh so pretty-sounding 
name. Osteogenesis imperfecta; it sounds like a flower or a type of bird, to those who 
have not studied Latin. But the truth is different. A life which from the very first 
awakening of the child (and her family!) is marked by pain, worry and isolation on the 
one hand and the urge to join in like everyone else does in society on the other. 
Because why shouldn't we, with our life-long wariness of danger, want go to school 
like other people, want to play with children of our own age, train for a job, find a 
partner and bring up children ourselves? 
To gain experience, which is such a natural thing for everybody else, we have to wage 
a fight. A fight with a variable outcome on the 'battle field'. Often our victories are 
followed by regressions which are difficult to swallow. Afterwards - and this has struck 
me since I have met other people with OI - after a long or short period of time, we 
return once again to the battle field. For whatever might have gone wrong with our 
genes, there is nothing wrong with our will power. This is of the utmost importance to 
people with this particular illness. 
If you are a spastic, or have rheumatism or polio, your life will undoubtedly be full of 
obstacles too. But there is one great difference: most people have at least heard of 
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the condition and have some sort of idea what it is - correct or not. Conversely, if you 
say, 'I have got osteogenesis imperfecta', hardly anyone knows what that is. (Haven't I 
been confronted so often with people in the medical profession who admit that they 
have to look it up in their books first, because the name rings a bell, 'but it is such an 
uncommon condition'). This sort of thing makes many of us shy away, and sometimes 
just weary. How are you supposed to explain time and time again that a cold hand 
grips your heart if someone shouts joyfully, 'Hey, it is going to snow!'; or that you 
worry if you have to go somewhere where they have just laid a beautiful new marble 
floor; or that when a dog runs up to you in the street it nearly scares you stiff, even 
though a passer-by says in a well-meaning way, 'Oh, he won't hurt you' ... No, he 
won't hurt me, but you stand there every time frightened silly. One wrong move, a 
fall, and you will be out of circulation again for weeks. More pain. Once again 
dependent on others. 
Prudence and care, they don't leave you alone for a second. And you can't explain 
that to all the 'passers by' in your life. Who does understand? Your family who have 
looked after you since the first day and - if you are lucky enough to have one - your 
partner or a good friend. Because explaining costs such a lot of energy and often, 
unintentionally, meets with a lack of understanding, we don't bother and end up 
forcing ourselves yet again. Still we enter the bank with the slippery floor, still we go 
outside in an autumn storm, still we wait patiently in the queue at the check-out, still 
we join in with everybody else. 
In this way we search every day for the brittle balance between the isolation of our 
limitations and the satisfaction of victory. And the latter - the relative victory over 
what we can do - is determined for the large part by will power. Will power is the 
priceless item that we grasp so tightly. Everybody searches for balance in his or her 
own way and that takes will power. My mother was right with her 'saxe porcelain'. It 
might be delicate and rare, but it is also priceless." 
Annemiek de Groot 
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SAKSISCH PORSELEIN 
'Toen ik nog een kind was noemde mijn moeder, die zich vaker van koosnaampjes 
bediende, mij 'poppetje van Saksisch porselein'. Klein als ik was, verbond ik geen 
speciale betekenis aan deze benaming; ik vond het enkel leuk. Pas veel later begreep 
ik dat dat een zeer juist gevonden betiteling was. Ik ben geen kenner van keramiek; 
bij 'saksisch porselein' heb ik vage associaties met pathetische beeldjes van pastorale 
herderinnetjes in zoetgevooisde kleuren. Maar ook met 'zeldzaam', 'kwetsbaar' en 
'fragiel'. En terwijl ik dit schrijf, met 'kostbaar', een betekenis die mijn moeder er 
ongetwijfeld óók mee bedoeld heeft. 
Dat wat kwetsbaar en teer is wordt doorgaans met zorg en voorzichtigheid behandeld. 
En dát is nu juist de crux, waar het bij ons, lijders aan de zo verraderlijke ziekte met 
de o zo fraai klinkende naam, om draait. Osteogenesis imperfecta; het lijkt wel een 
bloem of een vogelsoort, voor hen die het latijn niet zo machtig zijn. Maar de realiteit 
is anders. Een leven dat vanaf de allereerste bewustwording van het kind (en van de 
familie!) wordt gekenmerkt door enerzijds angst, pijn en isolement, anderzijds de 
drang om gewoon mee te willen doen in de maatschappij. Want waarom zouden wij, 
met onze levenslange waakzaamheid voor gevaar, niet nèt als ieder ander naar school 
willen gaan, met leeftijdsgenootjes willen spelen, een baan willen krijgen, een partner 
willen vinden en zelf kinderen willen opvoeden? 
Om al die ervaringen, die voor willekeurig welk ander mens zo vanzelfsprekend zijn, 
te kunnen opdoen, moeten we strijd leveren. Een strijd met een wisselend verloop op 
het 'slagveld'. Vaak wordt een overwinning weer gevolgd door een maar weer moeilijk 
te verkroppen terugval. Waarna, en dat is me opgevallen sinds ik meer mensen heb 
leren kennen die ook 01 hebben, na kortere of langere tijd het slagveld weer opnieuw 
betreden wordt. Want wát er ook fout mocht zijn gegaan met onze genen, aan onze 
wíl mankeert niets! Juist bij deze ziekte is dat zo belangrijk. 
Als je spastisch bent of reuma hebt of polio, heb je ongetwijfeld nèt zo'n leven vol 
obstakels. Maar er is één verschil: de meeste mensen hebben er wel eens van gehoord 
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en hebben er een -al dan niet juiste- voorstelling van. Als je daarentegen zegt: "ik heb 
osteogenesis imperfecta" weet praktisch niemand wat dat is. (Zelf heb ik toch ook 
regelmatig meegemaakt dat hulpverleners uit de medische hoek te kennen gaven eerst 
even in hun boeken te moeten kijken, omdat ze wel de klok hadden horen luiden, 
maar ja "het komt ook zó weinig voor"). Dát maakt velen van ons kopschuw en soms 
gewoon móe. Hoe kun je keer op keer uitleggen dat er een koude hand om je hart 
grijpt als iemand verheugd uitroept "Ha, het gaat sneeuwen!"; dat je bang bent als je 
ergens zijn moet waar nèt een prachtige nieuwe marmeren vloer is gelegd; dat een 
rennende hond op straat je de stuipen op het lijf jaagt, al zegt een voorbijganger 
goedbedoelend "Ach, hij doet niks"... Nee, hij doet niets, maar jij staat elke keer weer 
doodsangsten uit. Eén verkeerde beweging, een val, en je bent weer voor weken uit 
de roulatie. Weer pijn. Weer afhankelijkheid van anderen. 
Voorzichtigheid en zorg, het laat je geen seconde los. En dát is niet uit te leggen aan 
al die 'voorbijgangers' in je leven. Wie het wel begrijpen: je familie, die de zorg vanaf 
de eerste dag heeft gedeeld en -als je geluk hebt die te hebben- je partner of een 
goede vriend. Omdat het uitleggen zoveel energie kost en vaak op onbedoeld 
onbegrip stuit, laten we het maar en forceren we ons al te vaak maar weer. Tóch 
maar weer die bank in met die gladde vloer, toch maar weer naar buiten als er een 
herfststorm woedt, tóch maar weer geduldig wachten in de rij voor de kassa, tóch 
maar weer meedoen met de anderen. 
Zo zoeken we elke dag weer een broos evenwicht tussen het isolement van onze 
beperkingen en de voldoening van de overwinningen. En dat laatste -de relatieve 
overwinning op onze mogelijkheden- wordt voor een groot deel bepaald door wíl. Dat 
is het 'kostbare' wat we in handen hebben. Ieder zoekt dat evenwicht op zijn eigen 
wijze en daarvoor is wíl nodig. Mijn moeder had gelijk met 'saksisch porselein'. Het 
mag dan teer zijn en zeldzaam, het is ook kostbaar!" 
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behorende bij het proefschrift 
OSTEOGENESIS IMPERFECTA TYPE I 
OTOLOGICAL AND CLINICAL GENETIC ASPECTS 
A.J.T.M. Garretsen 
Nijmegen, 11 mei 1992 
1. Het voor osteogenesis imperfecta kenmerkende gehoorverlies komt bij alle 
vormen van osteogenesis imperfecta voor. 
2. Binnen een met-geselecteerde populatie van lijders aan osteogenesis 
imperfecta type I bedraagt de prevalentie van gehoorverlies 43%. 
3. Bij lijders aan osteogenesis imperfecta type I is tussen het 10e en 45e 
levensjaar een progressief gemengd gehoorverlies te verwachten, dat 
gemiddeld 1 decibel per jaar toeneemt. 
4. Het is gerechtvaardigd bij mensen met een gemengd gehoorverlies 
veroorzaakt door osteogenesis imperfecta, op jonge leeftijd een stijgbeugel-
vervangende operatie te verrichten, mede gezien de te verwachten progressie 
van het perceptieve gehoorverlies. 
5. De teleurstellende resultaten na een stijgbeugel-vervangende operatie bij 
osteogenesis imperfecta mogen met zonder meer de operateur worden 
aangerekend. 
6. Een stijgbeugel-vervangende operatie bij osteogenesis imperfecta behoort 
plaats te vinden in de handen van ervaren otologen, die met de ziekte bekend 
zijn. 
7. Men dient ervoor te waken, dat ouders van kinderen met recidiverende 
botbreuken met verdacht worden van kindermishandeling, of zelfs uit de 
ouderlijke macht worden ontzet, alvorens osteogenesis imperfecta als 
mogelijke oorzaak is uitgesloten. 
Voor het aantonen van het syndroom van Sjögren is het voldoende de 
reumafactoren en het anti-SS-B en anti-SS-A in het serum te bepalen. 
Door de grote kans op een vals-negatieve uitslag van het sialogram bij het 
syndroom van Sjogren is de waarde van dit onderzoek als diagnosticum 
achterhaald. 
Er zijn geen erger doven dan die niet horen willen. 
De vindingrijkheid van de partner van de promovendus neemt evenredig toe 
met de duur van het promotie-onderzoek. 



